Podcasts about Johns Hopkins

Around this time every year, dozens of parents of high school prospects ask IL's Terry Foy some version of the question, "How does recruiting work?"In an effort to round out that answer, he's interviewing DI men's lacrosse coaches about their process, continuing the fourth year of the "How Recruiting Works" series with Johns Hopkins coach Peter Milliman.The discussion begins as Milliman's traces the evolution of his principles of play and how they intersect with the way the game is played. From there, he outlines how his staff works together to develop a recruiting board, how he relies on his relationships high school and club coaches to get feedback on prospects (sharing a favorite nugget on the topic) and ends with a discussion of how the unique elements of the Blue Jays' athletic department — chiefly being a predominantly Division III institution in the Big Ten — informs how he regards on the ongoing changes in college athletics.

"If you are considering board service, I would say take the leap. Start with your local chapter. It will give you some valuable skills that will help prepare you when you are applying for your national level. And I always say, if you want to do it, just do it because what's the worst that can happen? They can say no, but that doesn't mean that you will never serve on a board. I always tell people delayed is not denied," Cassandra Green, DNP, RN, OCN®, ONS member and past president of the Oncology Nursing Certification Corporation (ONCC) Board of Directors, told Evelyn Wempe, DNP, MBA, APRN, ACNP-BC, AOCNP®, CRN, NEA-BC, chair of the ONS Leadership Succession Committee (formerly known as the Leadership Development Committee), during a conversation about service on a board of directors. Wempe spoke with Green and ONS members Kristin Ferguson, DNP, MBA, RN, OCN®, CGNC, former treasurer and director-at-large on the ONS Board of Directors, and Yanka Campbell, DNP, RN, CPHQ, AGPCNP-BC, CNE, member of the Oncology Nursing Foundation (ONF) Board of Directors, about their experiences with board service. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by August 28, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to serving on a board of directors for a professional organization. Episode Notes Complete this evaluation for free NCPD. ONS Podcast™ episodes: Meet the ONS Board of Directors series Episode 342: What It's Like to Serve on the Leadership Development Committee ONS Voice articles: Could Today Be the Start of Your ONS Leadership Journey? Nursing Leadership Unlocked Leading With Purpose Creates a Vision for the Future of Oncology Nursing ONS courses: A Guide to Chapter Leadership: Chapter President Training Board Leadership: Nurses in Governance Clinical Journal of Oncology Nursing article: Rearview Mirror Leadership: Looking Backward to Move Forward ONS Board Self-Assessment ONS Leadership ONCC Board of Directors ONF Leadership Your Roadmap to Future Service on the ONS Board of Directors ONS Leadership Learning Library To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode Campbell: "Joining a board was a natural next step for me to maintain my connection to bedside nursing that I've loved for so many years, and to find a way to give back to advanced practice nurses as well in this role. The Oncology Nursing Society and Foundation were especially meaningful for me because I knew firsthand the importance of having scholarship, research, funding, and leadership development programs that can really change the trajectory of a nurse's career. I realized I wanted to help shape the opportunities that were available to me for future nurses, and I just did not want to continue to do that through one-on-one mentorships, which I have done extensively throughout my career, but find a way to help more broadly toward guiding organizational mission and strategic objectives." TS 7:20 Green: "Everyone was so welcoming on the board. Everyone was so friendly. One of the first things I remember our executive director Tony Ellis telling me is, 'Most of our new board members are really quiet and reserved at our first meeting. They just kind of keep things to themselves. They don't ask a lot of questions.' I don't know if they were prepared for me because I came in with guns a-blazing, and I had lots of questions. I was not quiet. I was very involved and very vocal. I still am, but that was one of the best experiences ever. Before that, I had never really been in a board setting other than my local chapter, and even then, I was just starting to be in that setting because I was the president of my local chapter and on the [ONCC] Board of Directors at the same time." TS 10:29 Ferguson: "A nonclinical mentor I would absolutely identify would be Alec Stone, who used to be the ONS director of public affairs. … He helped me to learn a lot about health policy and advocacy and the impact a nurse's voice can have. Learning how to speak about my experiences in health care in public by doing programs like the Nurses in Washington Internship … or ONS's Capitol Hill Days ended up giving me a lot more confidence that I didn't know I would have in expressing my point of view and being very open and collegial and expressing my opinions. … This really lent itself well to my future board experience because, as Cassandra mentioned, board members have to speak their mind and speak up at the meetings." TS 12:11 Campbell: "One of the most unexpected benefits was when I reached out to my executive leadership team at the Kimmel Cancer Center at Johns Hopkins and said, 'I'm being considered to serve on the ONF Board. This is going to require me taking time away from work to attend meetings, to attend some in-person meetings. And then it would be really wonderful at the institution if I'm able to also financially impact the nurses who need to benefit from what I've benefited from in my career.' Usually when you have those conversations, you are expecting to present a deck of PowerPoint slides to make your case, but the answer from my leadership team in participating in ONF and supporting the Board was an immediate yes. It was 'Yes, when can you start? Yes, what can we do to support you?' And really making sure that I had dedicated time to be fully present." TS 14:15 Ferguson: "There are many skills and experiences that can lend themselves to being a strong board member. … The ability to speak your mind clearly and express your thoughts, which really boils down to strong communication skills. We are lucky in our careers. We all have worked as nurses in different settings and health care, and nurses are naturally skilled and good at communication. We learn strategies like SBAR—situation, background assessment, recommendation. Nurses every day are communicating in their places of work, oftentimes with patients who are sick and need education, or perhaps with new nurses they're teaching or mentoring. And they are communicating with non-nurses, as well, and nonpatients, so clinical roles and nonclinical roles. So nurses already have a good understanding of best practices when it comes to communication, and this can lend itself well to any board position." TS 21:04 Green: "When you [come into a] leadership role, I think that's when we learn most about ourselves and what we expect. And be the leader type of leader that you want to be and the type of leader that you would like to work with so that you can make your experience valuable and pleasurable." TS 28:57

In this week's episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl go in search of the facts beneath healthcare's biggest headlines. Today's show opens with one of the hottest and least understood medical topics: experimental peptides. Pearl explains that an FDA advisory committee narrowly recommended allowing compounding pharmacies to provide six experimental peptides to patients. This is not the same as traditional FDA approval. Rather than reviewing a drug through the usual three-phase clinical trial process, the recommendation would allow suppliers to provide peptide ingredients that compounding pharmacies could use to fill prescriptions. Pearl then explains why this distinction matters. If the FDA follows the committee's recommendation, many patients may assume the peptides have been vetted like other approved medications. He warns that this could leave the nation in a medical gray zone, with broad access but little rigorous evidence on safety, effectiveness, dosing or long-term risk. The episode then turns to several follow-up stories and new medical developments, including the cyclospora outbreak, CDC leadership, pediatric e-bike injuries, AI-designed viruses, Ebola, mRNA flu vaccines and the continuing politicization of vaccine policy: The cyclospora outbreak appears to be slowing, but the total case count remains high and the exact source has not been fully confirmed. Erica Schwartz has been confirmed as CDC director, becoming the agency's first full-time leader in a year. Pearl says Schwartz has strong credentials but will face major challenges, including depleted agency staffing, infectious disease outbreaks and political pressure around vaccines. Pediatric e-scooter and e-bike injuries surpassed 2,000 incidents from 2020 to 2024, according to data from Johns Hopkins researchers. Pearl warns that more states may need to restrict use among young children. AI can design viruses that do not currently exist in nature, a new Stanford study showed. This opens possibilities for new treatments but also raising biosecurity concerns. Pearl says the technology could one day help fight antibiotic-resistant bacterial infections, but it also raises concerns about bad actors. Ebola is spreading rapidly in the Democratic Republic of Congo, with more than 1,500 deaths and a mortality rate estimated at 40% to 50%. The FDA approved the first mRNA flu vaccine, developed by Moderna, for adults 50 and older. Pearl explains that mRNA technology could improve flu vaccination by allowing scientists to update vaccines closer to the arrival of each year's viral strain. The episode closes with Pearl's strongest warning: medical decisions made on politics rather than science lead to harm. He points to President Trump's executive order changing childhood vaccine recommendations and encouraging separation of the MMR vaccine into individual measles, mumps and rubella shots. Pearl says there is no scientific evidence supporting the president's claim that the combined MMR vaccine may be dangerous, while numerous studies show it is safe, effective and lifesaving. His conclusion: when scientific evidence is overwhelming, leaders need a compelling scientific reason to deviate from it. Whether the subject is experimental peptides, AI-designed viruses, mRNA vaccines or childhood immunization, medicine cannot protect patients if politics replaces data. Tune in to hear the full discussion and subscribe to Medicine: The Truth for more fact-based analysis of the medical, scientific and policy stories shaping American healthcare. * * * Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine. Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn. The post MTT #110: Peptides, politics & the perils of medicine without evidence appeared first on Fixing Healthcare.

We’re wrapping up the offseason, one in which we’ve now dropped 11 podcasts for you, including 24 coach and/or student athlete interviews, a commissioner and a collector of college football helmets. And we are here to get you into preseason camp, into your full pads and helmets and much more with Podcast 414. This edition of the D3football.com Podcast is sponsored by GameStrat, the most reliable & fastest in-game video replay system on the market. Find out more at GameStrat.com. Johns Hopkins is the preseason No. 4 team in our Top 25 poll, and coach Dan Wodicka was glad to talk to us during the middle of the Blue Jays’ preseason camp. Find out who the new JHU starting quarterback will be, where he came from, what else he does at Johns Hopkins, and what made his teammates vote him a captain before he has ever started a single football game for the program. Why do the Blue Jays carry just 100 players this year, and how does that compare to previous seasons? Who is wearing the honored No. 3 for Johns Hopkins this season? How well will the team reload at offensive line, where they lose four starters. And how well has JHU transitioned to new quarterbacks in the recent past? We also chat with Wes Dodson, head coach at LaGrange. The Panthers had a breakthrough season, going 10-2 and winning a first-round playoff game, and are looking to continue to push the program forward, just a few years after Dodson inherited a team which would go 0-9. The football team is a huge part of the campus culture at LaGrange, which is growing but still had under 650 full-time undergraduates last year. Secondary is the biggest spot to fill for the Panthers, while Henry Broadnax is a veteran returning at quarterback for LaGrange, coming back after playing hurt last season. Plus, how will the Top 25 poll react to the big games in the first two weeks of the season? Which Week 1 games between unranked teams do we have a particular eye on? That and more in this edition of the D3football.com Around the Nation podcast. The D3football.com Around the Nation podcast is a weekly conversation during the season, twice monthly in the offseason, about NCAA Division III football, and has been running since 2007. Hit play, or subscribe to get this podcast on your mobile device. You can subscribe to the Around the Nation Podcast in Apple Podcasts, and many other places. You can also get this and any of our future Around the Nation podcasts automatically by subscribing to this RSS feed: http://www.d3blogs.com/d3football/?feed=podcast Here’s how to find us on some of the major podcasting apps: Apple Podcasts: D3football.com Around the Nation Podcast Podcast Addict: D3football.com Around the Nation Podcast iHeart Radio: D3football.com Around the Nation Podcast Spotify: D3football.com Around the Nation Podcast Photos: David Hilbert, d3photography.com; Marty Corcoran, Johns Hopkins; Rachel Staub, Washington & Jefferson

About this episode:   At the turn of the 20th century, waterborne diseases like typhoid and dysentery posed a significant threat to public health, accounting for a large part of infant mortality and overall morbidity. Enter Abel Wolman, an early graduate of Johns Hopkins' engineering program and a professor at the university's school of public health. In this episode: the story of the Baltimore-born pioneer of water sanitization and how his work in water chlorination and infrastructure set the stage for better health across the globe.  Note: This episode was produced in collaboration with the Johns Hopkins University sesquicentennial campaign.  Guest:  Graham Mooney, PhD, is an associate professor of history of medicine and epidemiology at the Johns Hopkins School of Medicine.  Host:  Ari Goldstein, MD, is a family medicine physician and a recent alum of the Johns Hopkins Bloomberg School of Public Health General Preventive Medicine Residency program. This year, Dr. Goldstein served a one-month rotation with Public Health On Call.  Show links and related content:  Heroes of Public Health: Abel Wolman—Johns Hopkins Bloomberg School of Public Health  Friend of the Thirsty—New York Times

What if everything you believe about why you are 'you' is wrong? My guest today has spent his career studying the brain at Johns Hopkins — and a few years ago, he was told he had six to twelve months to live. Today, we're talking about what he's learned on both sides of that line. We're going to get into why 'nature versus nurture' is, in his words, scientifically lazy — and what's actually shaping your personality, your preferences, even who you're attracted to. We're going to talk about a discovery about sexual sensation in the body that's only a few years old. And we're going to talk about what facing death taught him about time, gratitude, and identity that no textbook ever could. Stick around — this one gets personal fast   Connect With David Linden: Web: https://davidlinden.org Facebook: https://www.facebook.com/davidlindenauthor   Follow Dr. JC Doornick and the Makes Sense Academy:► Makes Sense Substack - https://drjcdoornick.substack.com ► Instagram: / drjcdoornick ► Substack: / drjcdoornick ►Facebook:  / makessensepodcast ►YouTube:  / drjcdoornick     MAKES SENSE PODCAST Welcome to the Makes Sense with Dr. JC Doornick Podcast. This podcast explores topics that expand human consciousness and enhance performance. On the Makes Sense Podcast, we acknowledge that it's who you are that determines how well what you do works, and that perception is subjective and an acquired taste. When you change the way you look at things, the things you look at begin to change. Welcome to the uprising of the sleepwalking masses. Welcome to the Makes Sense with Dr. JC Doornick Podcast.   SUBSCRIBE/RATE/REVIEW & SHARE our new podcast. FOLLOW Podcast: You will find a "Follow" button in the top right. This will enable the podcast software to alert you when a new episode launches each week. Apple: https://podcasts.apple.com/ca/podcast/makes-sense-with-dr-jc-doornick/id1730954168 Spotify: https://open.spotify.com/show/1WHfKWDDReMtrGFz4kkZs9?si=003780ca147c4aec   Podcast Affiliates: Kwik Learning: Many people ask me where I get all these topics, which I've been covering for almost 15 years. I have learned to read nearly four times faster and retain information 10 times better with Kwik Learning. Learn how to learn and earn with Jim Kwik. Get his program at a special discount here: https://jimkwik.com/dragon OUR SPONSORS: Operly - Take Back Control of Your Work Day and Get Rid of All Your AI Apps - Welcome to the new world of Time Freedom and Unlimited Scaling and Success with Operly -  https://go.getoperly.ai/video?ref=jean-claude-claude-d-2a95 Blue Blinds Bakery - Handcrafted with all-natural ingredients - www.blueblindsbakery.com     DAVID LINDEN TIMESTAMP 00:00 - Cold Open and Meeting Dr. David Linden 03:08 - Facing Cancer: David's Diagnosis and JC's Own News 06:00 - Why "Unique" Needed to Be Written 09:49 - The Third Factor: Why Identical Twins Differ 13:30 - The Heritability Spectrum: Earwax to Accent 17:11 - Intelligence, Addiction and Personal Responsibility 22:32 - Why Healthy People Still Get Cancer 24:58 - When Individuality Begins: Life Before Birth 29:39 - Cilantro, Taste and the "Anti-Panda" Diet 32:54 - Diet Advice and the Truth About Supplements 36:32 - Certainty, Curiosity and the Scientist's Mindset 39:24 - Science Evolving: Being Wrong and Staying Humble 44:25 - Open Questions: Sexuality and Revising "Unique" 47:35 - Lightning Round: Myths, Memory and a Favorite Book 52:39 - ending: New Book, Where to Find David and Sign-Off  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

About this episode:   Long flights at high altitudes can expose pilots and flight attendants to dangerous levels of cosmic radiation over their careers, potentially increasing their risk for a variety of cancers and posing special dangers to pregnant crewmembers. In this episode: a new report from the National Academies of Sciences, Engineering, and Medicine urges action on in-flight radiation exposure, including mandating airline safety programs and developing new ways to measure hazards. Guest:  Tom Burke, PhD, MPH, is an emeritus professor at Johns Hopkins and a former top official with the Environmental Protection Agency in the Obama administration. Lindsay S. Fenwick is an accomplished pilot with over 21,000 flight hours spanning military, corporate, VIP, and major airline operations. He also has extensive experience in aviation safety management. Host:  Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. He served as the Baltimore City Commissioner of Health from 2005 to 2009.  Show links and related content:  Assessing Radiation Exposure, Health Outcomes, and Mitigation Strategies for Flight Crewmembers—National Academies of Sciences, Engineering, and Medicine Aircrew and Cosmic Ionizing Radiation—CDC Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

GLP-1 receptor agonists have transformed weight loss and metabolic health—but what are we overlooking? In this episode of New Frontiers in Functional Medicine, Dr. Kara Fitzgerald is joined by Dr. Sanjay Bhojraj and Dr. Alexis Gonzales to explore the clinical tradeoffs of GLP-1 therapy, including lean muscle preservation, nutrient status, weight regain, and long-term metabolic health. The conversation also examines SiPore, an engineered silica-based intervention that works locally in the GI tract to slow the breakdown and absorption of carbohydrates and fats. Dr. Fitzgerald and her guests discuss findings from the randomized, double-blind, placebo-controlled SHINE trial, including outcomes related to A1c, visceral fat, waist circumference, cholesterol, and lean mass. They also explore how CGMs can reveal post-meal glucose patterns, why muscle preservation matters during weight loss, and how clinicians can support patients transitioning off GLP-1 medications—including those preparing for pregnancy, IVF, or surgery. Full show notes + references: https://www.drkarafitzgerald.com/fxmed-podcast/ GUEST DETAILS Sanjay Bhojraj, MD, FACC is an interventional cardiologist and Fellow of the American Academy of Anti-Aging Medicine specializing in cardiometabolic health, longevity medicine, and precision cardiovascular prevention. He's the founder of the Laguna Institute of Functional Medicine. His programs focus on reversing metabolic dysfunction, improving resilience, and reducing cardiovascular risk through lifestyle optimization and advanced diagnostic testing. Dr. Alexis Gonzales ("Dr. G") is OvationLab's Senior Clinical Implementation and AI Specialist, translating breakthrough research into practical clinical workflows, and holds advanced degrees in biochemistry (Saint Mary's), biotechnology (Johns Hopkins), and naturopathic medicine (Bastyr). She provides concierge functional-medicine care at her private practice in California—focusing on endometriosis, fertility, PCOS, and menopause—while distilling emerging research into practical frameworks at conferences to make integrative solutions accessible. http://sigridpro.com/DRKF THANK YOU TO OUR SPONSOR SIGRID http://sigridpro.com/DRKF *CONNECT with DrKF* Want more? Join our newsletter here: https://www.drkarafitzgerald.com/newsletter/ Or take our pop quiz and test your BioAge! https://www.drkarafitzgerald.com/bioagequiz YouTube: https://tinyurl.com/hjpc8daz Instagram: https://www.instagram.com/drkarafitzgerald/ Facebook: https://www.facebook.com/DrKaraFitzgerald/ DrKF Clinic: Patient consults with DrKF physicians including Younger You Concierge: https://tinyurl.com/yx4fjhkb Younger You Practitioner Training Program: https://www.drkarafitzgerald.com/trainingyyi/ Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw

Our hearts are restless, says Saint Augustine, until they find their rest in God. The biological science and the spiritual metaphor are in agreement here. Over the course of billions of beats, our hearts never stop to rest.  Your magnificent heart exchanges or pumps your entire blood volume, just over a gallon, every single minute. (Athlete hearts can pump up to 10 gallons per minute!) In this episode, Mark Labberton discusses matters of the heart with his close friend Dr. David Anderson, a cardiologist of four decades who trained at Johns Hopkins and helped launch one of the first interventional cardiology programs in San Francisco. Anderson reflects on the medical science of cardiology, the profound life-saving medical advances over the past forty years, heart disease versus coronary artery disease, how the brain and the heart communicate, and what happens during a heart attack. In the second half of their conversation, they move from physiology to spirituality of the heart: Pharaoh's hardened heart, "out of the heart the mouth speaks," and the human need to find somewhere to locate the self. Anderson closes with what a cardiologist would tell anyone worried about their own heart, and with a case for medicine as a noble profession. Episode Highlights "When I first began in cardiology, if your heart was damaged, imagining that the heart could actually improve its function was like imagining someone could grow back a new arm." "One of the distinctive things about the heart is unlike other muscles, it doesn't have a time to rest. When it gets insufficient blood supply, it can't just say, 'Whoa, I'm gonna stop here.' It asks you to slow down because it starts hurting." "I think that's part of the intrigue of the heart, that it is inside us … but in some ways it's apart from us. It's responding to environmental things that we're not really even aware of. … I think it's this sense of detachment of the heart from us—but yet its centrality—that has led people to posit the soul or the will or the passions or almost anything that you would think was the real you. "Atherosclerosis … I would describe as it's like having a pimple inside your artery." "First of all, know yourself. That is, it's not a time to be fatalistic because your father had a heart attack in his fifties or your brother just had a heart attack. It's a time to be proactive." About David Anderson David Anderson is a cardiologist who practiced for more than four decades before retiring. He studied at Stanford as an undergraduate and earned his medical degree at Johns Hopkins University School of Medicine. He stayed at Hopkins for residency, then trained in San Francisco at the dawn of interventional cardiology, helping to build an angioplasty program in the early 1980s. Helpful Links and Resources Alta Bates Summit Medical Center, Sutter Health, the Oakland hospital Anderson thanks by name: https://www.sutterhealth.org/about-us/our-hospitals/alta-bates-summit-medical-center DeWood et al., "Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction," the 1980 study that identified clot as the cause of heart attack: https://www.nejm.org/doi/full/10.1056/NEJM198010163031601 Waagstein et al., "Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy," the Swedish beta-blocker work behind the recovery he describes: https://pubmed.ncbi.nlm.nih.gov/1191416/ What Is Atherosclerosis, National Heart, Lung, and Blood Institute: https://www.nhlbi.nih.gov/health/atherosclerosis Warning Signs of a Heart Attack, American Heart Association: https://www.heart.org/en/health-topics/heart-attack/warning-signs-of-a-heart-attack Angina (Chest Pain), American Heart Association, on the exertional pain he describes at the close: https://www.heart.org/en/health-topics/heart-attack/angina-chest-pain Show Notes The impact of family gene pool, lifelong heart awareness How David Anderson got into medicine, and cardiology in particular A Hopkins autopsy elective, a teenager dead in a parking lot, a mentor who followed From internists interested in the heart to interventionists inside it Catheters, pressures, and the arrival of echocardiography Seeing a beating heart inside a living body for the first time, as a senior resident A colleague's heart attack in 1979 The 1980 angiography study that identified clot as the trigger Spring 1983: an artery occludes, the cath lab opens it, pain gone in fifteen minutes Bypass surgery before that: elective, scheduled, never mid-attack Prevention running under the technology: blood pressure, smoking, the lipid theory Fixing one artery and never having to fix another Coronary artery disease versus disease of the muscle itself Plasticity, not regeneration Adrenaline as an emergency system built for days, not decades Moving from technological advances to molecular-based understanding of heart problems Understanding of the pathophysiology of atherosclerosis and its prevention Beta blockers, ejection fraction, and hearts that came back The heart as a muscle with no rest The heart's own electrical center, and the backup pacemakers below it Your heart doesn't rely on you or your consciousness to beat Why the ancients may have located the self in the heart organ Jeremiah's pounding heart, Pharaoh's hardened one Pascal, the soul, and needing somewhere to put "the real you" Maintaining an appropriate degree of separation from the patient and their family in order to care properly and effectively The difficulty of delivering bad news to patients and their familes Digging for a shared history to call on in a crisis "Medicine is a noble profession." Heart care advice from a cardiologist: First, know yourself. Heart health checklist: cholesterol, blood pressure, weight, knowing your own history The pain that warrants a phone call #Conversing #MarkLabberton #Cardiology #Heart #MedicalScience #HeartHealth #Biology #ChristianHumanism Production Credits Conversing is produced and distributed in partnership with Comment magazine and Fuller Seminary.

Rachel Pigott works as an occupational therapist and serves as the Director of the Hand Therapy Fellowship at Johns Hopkins. In 1999, she received her bachelor's in occupational therapy from Towson State University and in 2016 she completed her Master's in Public Health at The University of Massachusetts Amherst. Rachel is both a certified hand therapist and certified lymphedema therapist. She has served on a volunteer basis with the American Society of Hand Therapists since 2009 and currently serves on the ASHT DEI Committee, ASHT Independent Finance Committee, and as the ASHT Annual Meeting Chair. Rachel is also a past president of ASHT. Rachel's preferred pronouns are she/her/hers. She has presented on various topics in hand and upper extremity rehabilitation including arthritis, wrist instability, fractures, trauma, patient centered care, orthotics, anatomy of the wrist, gender affirming care for the upper body, and lymphedema management and prevention related to breast cancer related lymphedema.Guest Bio: Rob McClellan has 23 years of experience working in hand and upper limb rehabilitation. He is an active member of the American Society of Hand Therapists serving on the Board of Directors as Secretary/Treasurer, and the Diversity, Equity, and Inclusion Committee. He is an active member of the American Association for Hand Surgery and is a past President of the Georgia Hand and Upper Extremity Special Interest Group. Rob is the Hand Program Coordinator for Physio/ Select Medical in Georgia-The views and opinions expressed in the Hands in Motion podcast are those of the guests and do not necessarily reflect the official policy or position of ASHT. Appearance on the podcast does not imply endorsement of any products, services or viewpoints discussed.

In his weekly clinical update, Daniel Griffin and Vincent Racaniello are troubled by the latest executive order changing routine childhood vaccine recommendations, the call for nominations to join the Advisory Committee for Immunization Practices, West Nile virus transmission in South Carolina, a newly identified midge-transmitted virus sickening cattle, and development of a cold-chain free DPT vaccine, the national cyclospora and screwworm outbreaks,new screwworm and genomics of Ebola outbreak in the Congo, and use of a mismatch vaccine to combat the Bundibugyo virus outbreak before Dr. Griffin deep dives into the measles outbreak, recent statistics on RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, how to access and pay for Paxlovid, where to go for answers about long COVID-19, clinical guidelines for treating long COVID, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode DELIVERING GOLD STANDARD CHILDHOOD VACCINE RECOMMENDATIONS FOR AMERICANS (Whitehouse) Trump signed an executive order calling for fewer childhood vaccines (NY Times) CIDRAP Op-Ed: What the vaccine executive order gets wrong, and what it will cost us (CIDRAP) New CDC director faces first major test before she even begins work (CIDRAP) National Vaccine Advisory Committee (US Department of Health and Human Services) Solicitation of Nominations for Membership on the National Vaccine Advisory (Department of Health and Human Services) DPH Announces West Nile Virus Outbreak in Pee Dee South Carolina Department of Public Health) Newly discovered virus is sickening cattle in Western Europe (Science) Safety, tolerability, and immunogenicity of SPVX02, a room temperature-stabilised tetanus-diphtheria vaccine, compared to two established tetanus-diphtheria booster vaccines: a multicentre, single-blind, randomised, first-in-human phase 1 trial in the UK (eClinicalMedicine) Surveillance of Cyclosporiasis (CDC: Cyclosporiasis) Infectious DiseaseOutbreaks (Michigan: Health & Human Services) Cyclosporiasis Cases in North Carolina (North Carolina: Division of Public Health) Cyclospora Infection (Cyclosporiasis) (NYC Health) Missouri Communicable Disease Report (2026) (Missouri Health) TWiP 285: Why is cyclospora hard to contain: Parasitologists explain the 2026 US outbreak (microbeTV:TWiP) Dashboard SCREWWORM.Gov (USDA: Animal and Plant Health Inspection Service) CDC Activates Emergency Operations Center for New World Screwworm Response (CDC Newroom) Human Myiasis Resulting from Reemergence of Cochliomyia hominivorax Screwworm, Mexico, 2025–2026 (Emerging Infectious Diseases) Ebola dashboard (ebola.fyi) EBOLA: The Democratic Republic of the Congo, 2026 (WHO) Bundibugyo virus disease outbreak Democratic Republic of the Congo (WHO: Democratic Republic of Congo) Ebola Outbreak: Current Situation (CDC:Ebola) Mismatched vaccine being rolled out against Ebola outbreak (Science) Emergence of a Bundibugyo virus variant in the 2026 outbreak in the Democratic Republic of the Congo and Uganda (Nature Medicine) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard (South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) Utah Measles Dashboard (Utah Department of Health and Human Services) Measles (VDH: Virginia Department of Health) Tracking Measles Cases in the U.S. (Johns Hopkins) HAP's Latest News Pa. Launches New Measles Dashboard (Hospital + HealthSystem Association of Pennsylvania) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Kennedy Stirred Vaccine Fears in Pennsylvania Years Before Measles Outbreak (NY Times) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) FDA vaccine advisers recommend adding subclade K to fall shots (CIDRAP) Weekly surveillance report: clift notes (CDC FluView) Effectiveness of Oseltamivir in Hospitalized Children With Laboratory-Confirmed Influenza, 2014-2023 (JAMA Pediatrics) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-Elicited SARS-CoV-2 Immune Responses (JID) Clinical practice guideline for long COVID prevention and treatment (ERS) Reaching out to US house representative Letters read on TWiV 1348 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

He moved to Hollywood with $43 and a dream. Watched his dad pour brilliant ideas into businesses that made other people rich. Decided the only thing scarier than risking everything was never finding out what he was capable of. Twenty-five years and 51 countries later, Caleb Gilbert protects the world's most elite. And everything he's learned doing it maps directly into how you're building your business right now. Caleb Gilbert is the founder of White Glove Protection Group and a global expert in executive protection. In this conversation, he and George translate the frameworks used to protect A-list celebrities and Fortune 200 companies into a masterclass on entrepreneurship, covering risk, trust, vision, proactive vs. reactive posture, and what it really means to be all in. What You'll Learn In This Episode: How executive protection frameworks apply directly to building a business Why your relevance is entirely based on the perceived value of your consumer The difference between being energetically all in vs. financially all in Why Caleb turned down $1.5M in business to protect his vision and how it led to 4,000% growth How to build a proactive business posture instead of a reactive one The one question that revealed imposter syndrome was costing him clients Why grit, not tactics, is the most transferable skill from protection to entrepreneurship Key Takeaways: ✔️Your relevance is based on the perceived value of your consumer, not what you think they need. Flip the script. ✔️Being energetically all in and being financially all in are not the same thing. The people around you will tell you when you're truly all in, they'll tell you you're overdoing it. ✔️Zero revenue for two years. Turned down $1.5M. Then 4,000% growth. Knowing your vision and protecting it is a competitive strategy. ✔️Proactive posture beats reactive posture every time, in protection and in business. Stop waiting for the threat. Get ahead of it. ✔️The biggest threat your business faces is distraction. Not competition. Not market conditions. Distraction. ✔️Nobody else has your brain, your context, your background. The moment Caleb stopped trying to be a Navy SEAL and started leading with his actual edge, everything changed. ✔️Don't let money be your north star. If vision, strategy, and execution align with what the market needs, the money follows. ✔️Reinvest like you're still building. A $1.50 lawn mower became a business, because every dollar went back in. Timestamps & Highlights: [00:00] — $43, a dream, and the mindset that made it work [01:26] — Welcome: 25 years, 51 countries, and the White Glove difference [03:16] — Montana grit: why hard things inspire instead of dissuade [06:28] — Environment that demands vs. inspires and what that means for your team [07:33] — Starting at age 11: Nike socks, lawn mowers, and learning risk vs. reward early [11:03] — How to mitigate risk without impeding what makes your business great [13:07] — "Your relevance is based on the perceived value of your consumer" [18:00] — The onboarding parallel: walking clients through what they've never experienced [21:00] — Client number one, staying in vision, and zero revenue for two years [24:17] — Energetically all in vs. financially all in, how to tell the difference [28:34] — The 2020 gut check: when a CEO told Caleb not to chase money [35:00] — Ego in the protection industry and how Caleb navigated it [43:00] — Imposter syndrome, 86% prior military, and the moment he found his edge [50:00] — Proactive vs. reactive posture in business and protection [55:00] — Reinvesting like you're still building: the $1.50 lawn mower origin story [59:43] — Caleb's closing wisdom: be proactive, know your strengths, hit refresh Connect with Caleb Gilbert:  Founder and President of White Glove Protection Group, with 25 years of executive protection experience across 51 countries. He holds a Master's in Global Security Studies from Johns Hopkins and has trained at Stanford and ESI. He currently serves as Vice Chair of the ASIS Executive Protection Community and Treasurer of the IPSB Board. LinkedIn: linkedin.com/in/epcaleb Instagram: instagram.com/w.g.p.group.inc YouTube: youtube.com/channel/UCepN8VJqAXFahvbtfHxdcoQ Website: whitegloveprotection.com Your Challenge This Week: What's the one thing from this episode you can apply tomorrow: grit, proactive posture, protecting your vision, or leaning into your actual edge? Let George know. And if you have a security question for Caleb, he genuinely welcomes the conversation. Follow George: @itsgeorgebryant Work with George: The Alliance — Community for entrepreneurs building with vision, grit, and integrity. 1:1 Coaching — Limited spots. Apply at mindofgeorge.com/coaching-consulting/ Live Retreats — In-person experiences for entrepreneurs ready to stop reacting and start leading.

What I Discussed With Dr Arthur Burnett...- Why the pill has never once started an erection, and what that means for the nights it did nothing- The name he would give erectile dysfunction if he could rename it tomorrow- What his lab found when they went looking for the same response in women- Why the men who most want the pill to work are the ones it helps least- What he thinks of a prescription that takes four clicks and no conversation- The sentence surgeons skip before a prostatectomy, and why he takes the blame for it- What he does when he finds his own name on a supplement bottle- What he refuses to write a prescription for, no matter who is askingChapters00:00 – Intro & Sponsor Spotlight (https://www.ohmibod.com/) 00:26 – Redefining Intimacy After 50: Welcoming Johns Hopkins Urologist Dr. Arthur Burnett 01:33 – Is Erectile Dysfunction Inevitable? Why Unreliable Erections Don't Mean the End of Your Sex Life 02:18 – The Real Science Behind Viagra: What a Pioneering Researcher Wants Men to Know 04:29 – The Hidden Danger of Quick-Fix Online Prescriptions & Skipping Root Causes 07:24 – Removing the Shame: Why Men Must Stop Suffering in Silence 08:30 – Erectile Dysfunction as an Early Warning Sign for Heart & Vascular Health 10:19 – Does Viagra Work for Women? The Truth About Female Clitoral Blood Flow 12:31 – Sponsor Spotlight (GITM Playbook) 13:10 – Why the Blue Pill Doesn't Work Without Mind-Body Synergy 16:23 – Rethinking Performance: Shifting Focus Beyond Penetrative Sex 17:06 – The Unspoken Trauma: What Doctors Often Miss in Prostate Cancer Care 19:39 – Innovations in Prostate Surgery: Preserving Nerve Function & Recovery 20:58 – Post-Surgery Rehabilitation: Do Vacuum Pumps & Therapy Devices Actually Work? 22:29 – How to Talk to Your Partner About Sexual Decline Without Losing Attraction 23:33 – Lifestyle Habits That Naturally Improve Blood Flow & Performance 24:30 – Nitric Oxide Supplements: Separating Hype from Real Medical Science 28:01 – Authentic Health: Ditching the “Marlboro Man” Myth & Taking Charge Show NotesMost men over 50 assume their erections changed because they got older. Dr Arthur Burnett has spent forty years trying to tell them otherwise, and for most of those years he has been shouting into the wind.In this episode I'm joined by Dr Arthur Burnett, a urologist at Johns Hopkins, where he has worked for more than four decades. His laboratory did the discovery work in the late 1980s that made the blue pills possible. So I opened by asking him whether he regrets what men have done with them since.Two of the men I loved died. Both of them started here, and I read it as age. One had diabetes and told me flatly that the pill wasn't working, and I believed him. Dr Burnett listened to that story and told me what had been going on inside that man's body while I was busy blaming the wrong thing entirely.He is just as blunt about his own profession. He has watched surgeons treat the cancer and skip the man, and he does not exempt himself from it.There is no shame in this conversation and no bravado either. If your erections have changed and you have been waiting quietly for them to sort themselves out, this is the episode that tells you what you are actually waiting on.Listen, learn and enjoy.Key Takeaways- The oral medications release the brakes on an erection. They cannot start one. Arousal has to be driven from the brain and the body first, which is why a man can take the pill, feel nothing, and wrongly conclude he is finished.- Dr Burnett would call it penile vascular dysfunction. An erection runs on blood vessels, nerves and hormones, the same system that runs the heart, and it usually falters before anything else does.- His lab found the same nitric oxide response in clitoral tissue. The mechanics are close to identical, but female arousal involves hormones and other factors, so one pill was never going to be the answer.- Diabetes damages nerve and blood vessel tissue and behaves in the body almost like premature ageing. These men need more stimulus to drive the response, and the drugs work measurably less well for them.- The online questionnaire skips the health workup. Erectile dysfunction should send a man for a full check, and Dr Burnett calls home delivery without a clinician an unfortunate development in his field.- Nerve sparing surgery lifted recovery rates above zero. Surgeons now map the nerve pathways during the operation, man by man, though the results are still not where he wants them.- He has little faith in nitric oxide supplements and has found his own name on products he knew nothing about. His position comes from society guidelines rather than his own opinion.- Sleep, weight, smoking, movement, stress, cardiovascular health, checkups. He will not be asked for a miracle by a man smoking three packs a day, and says this layer comesAbout the GuestArthur L. “Bud” Burnett II, MD, MBA, FACS, is a globally recognized Johns Hopkins urologist, researcher, Viagra Pioneer, and educator whose pioneering work in men's health and erectile function has transformed care worldwide.About SuzanneSuzanne Noble is a sex and relationship expert, author, and host of the Sex Advice for Seniors podcast, one of the top-rated shows empowering people 50+ to embrace confident, joyful intimacy. Known for her candid, warm, and often humorous approach, Suzanne challenges age-related taboos, misinformation, and awkward conversations about sex after 50. She helps millions around the world navigate their sexual lives with pleasure, connection, and self-assurance. Because life is too short for bad sex... or silence about it.Connect With SuzanneInstagram: https://www.instagram.com/sexadviceforseniorsFacebook: https://www.facebook.com/sexadviceforseniorsTikTok: https://www.tiktok.com/@sexadviceforseniorsSubstack: https://www.sexadviceforseniors.comConnect with Dr Arthur BurnettWebsite https://drarthurburnett.com/Instagram https://www.instagram.com/dr.arthurburnett/YouTube https://www.youtube.com/@DrArthurBurnettFacebook https://www.facebook.com/DrArthurLBurnett/Want More?Visit the Website: https://sexadviceforseniors.com — includes FREE guides and resources for better sex at any age.Free Downloadable Guide: 10 Most Overlooked Secrets to Better Sex PDF: https://subscribepage.io/suzannenoblefreebieSign Up for My FREE Newsletter: https://sexadviceforseniors.comOvercome Erectile Dysfunction & Stay Firm: https://www.stayfirmprogram.comCheck Out My Storefront for Better Sex: https://zaap.bio/stayfirmInterested in 1:1 Coaching or Custom Sex Advice for Seniors Sessions? https://tidycal.com/suzannenoble/30-minute-mentoringRelated EpisodesThe Hidden Habits Destroying Men's Erections | ft. Tom Jenkins https://www.sexadviceforseniors.com/p/the-real-cause-of-erectile-dysfunctionWhy Sex Changes After 50 and What Nobody Tells You | ft. Dr. Jenn Kennedy https://www.sexadviceforseniors.com/p/why-sex-changes-after-50-and-what This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sexadviceforseniors.com/subscribe

The story told by our guest Patrick Hahn of how the medical industry has taken advantage of people who wish they had been born a different sex is appalling, heartrending, and a lesson from the extremes to which modern medicine can become perverted against the very people it is supposed to serve. Anyone who thinks they were mistakenly born into the wrong body has a tragic story to tell about how they became alienated from themselves while growing up. Instead of helping people recover their identity as a male or female human, in all its glory, and with all its complications, modern medicine is making billions of dollars by taking advantage of this vulnerability and pretending that the proper approach is to medically attempt to change their sexual identity by mutilating their bodies through highly dangerous and permanent surgical and medical interventions. In an especially tragic twist, the sex change industry has now targeted children, some as young as toddlers, beginning with indoctrination and leading to “puberty blocker” hormones to prevent the natural maturation of the individual. These early medical interventions often lead to surgery to remove breasts, vaginas, or penises as if in collaboration with the psychological demons that these individuals need to overcome. It's gotten so bad that one state has just authorized interchangeable body parts in an “anatomically correct doll to be used in public school sex education. The industry of so-called “gender affirmation” continues to be a “third rail”—dangerous to touch in any critical manner. People are stifled publicly and privately from speaking about this issue in a critical manner because they have been told they will cause so much pain and prejudice if they do. But the real suffering is being perpetrated by medical professionals, hospitals, and therapists who encourage the fantasy that one can change their sex to improve their quality of life. The reality is quite dismal in terms of outcomes. In every area in which our guest Patrick Hahn addresses the real science behind medical and psychiatric interventions, including his most recent book on the sex change industry, Patrick Hahn writes the most comprehensive, interesting analyses available. Where our books dovetail with his, and they often do, we nonetheless learn a great deal from him. If you've never heard him speak before, listen to this show simply for the pleasure of hearing one of the most brilliant and thoughtful critical researchers in the field of medicine and psychiatry today. This week on The Breggin Hour, Patrick Hahn joins us to discuss his powerful new book, Irreversible. Patrick is a careful researcher and a clear writer who has spent years documenting the medicalization of ordinary human suffering. His latest work traces how the obsession with “sex change” moved from a tiny fringe subculture to a multi-billion-dollar industry in the United States alone—and how that industry rests on a mountain of lies and deceptions. Patrick does not mince words. “There is nothing good about this industry. Nothing,” he told us. “The whole industry is based on lies.” In biology and medicine, he reminds us, nothing is more certain than this: there are two, and only two, sexes. It is impossible to turn a man into a woman with a surgeon's knife. When an entire medical enterprise begins with that lie, the rest of the story unravels into incoherence. Activists insist that “trans women are women,” then demand fantastically expensive surgeries and lifelong cross-sex hormones precisely so those same individuals can resemble women. If they already are women, why the need for the knife and the drugs? The most comprehensive long-term study ever conducted, from Sweden (one of the most “trans-friendly” countries on earth), found that after surgical transition the suicide rate was elevated by a staggering nineteen times compared with matched controls from the general population. Not nineteen percent higher—nineteen times as many suicides. There is no credible data showing that these procedures reduce suicide risk. The “transition or die” claim pushed on desperate parents is itself a lethal lie. As Patrick put it, “Trans and die” would be more accurate. Most gender-distressed children simply outgrow the distress if they are allowed to go through natural puberty. That is why the industry is so eager to block puberty. The “cure,” as Patrick observed, is puberty itself. When clinics rush children onto blockers and then hormones, they are manufacturing lifelong medical patients out of young people who would otherwise have resolved their confusion. How did this twisted field get its beginning? The founding figures—Harry Benjamin, John Money, the early directors of the Johns Hopkins clinic—were often more candid than today's activists about the role of childhood trauma, family dynamics, and social rejection. The first gender clinics in the United States and Europe eventually closed after their own research failed to show meaningful improvement. Those early practitioners had the intellectual honesty to admit failure. Their successors had a simple self-serving answer: if adults do not improve, start younger. The human toll in the sex change medical industry is incalculable. And the financial remuneration is staggering. An industry estimate of two billion dollars a year in the United States is almost certainly a gross undercount; it leaves out hormones, blockers, the cascade of complications, the “affirming” therapy that keeps families compliant, and the repeat surgeries required to repair damage from previous ones. Projections of five billion by 2030 still understate the true cost—human as well as monetary. We heard heartbreaking stories of families torn apart in court when one parent seeks to medicalize a child, and the other resists. We discussed the strange cultural power of celebrities who treat their children's bodies as fashion statements. And we noted the encouraging signs that the political tide is finally turning– federal funding streams are being cut, and people are less afraid to speak the obvious truth. Patrick's larger point is one we have long shared. The sex-change industry is only the sharpest edge of a broader medicalization of life. Once institutions stop caring whether people are productive and start treating them primarily as consumers of medical interventions, almost any human distress can be turned into a lifelong customer base. The damage done to children in the name of “gender affirmation” is irreversible. That is why the book is titled as it is. We urge you to read Irreversible. It is thorough, carefully documented, and written with genuine compassion for the people caught in this industry. You can find it, along with Patrick's earlier books on psychiatric drugs, ADHD, COVID policy, and genetic determinism, at patrickhahn.net.

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: American healthcare is at a crossroads, and the decisions we make now will define the health of generations to come.Dr. Marschall Runge has spent more than four decades at the center of that challenge, serving as former CEO of Michigan Medicine, Dean of the University of Michigan Medical School, and EVP for Medical Affairs.A practicing cardiologist trained at Johns Hopkins and Massachusetts General Hospital, Dr. Runge brings both the scientist's rigor and the leader's vision to one of the most urgent conversations of our time.In his Amazon and USA Today bestselling book, "The Great Healthcare Disruption," he lays out a bold prescription for reimagining American medicine through AI, innovation, and courageous systemic change.Join us to discover what it truly takes to transform healthcare from the inside out. Let's go!Episode Highlights:Dr. Runge never planned to be a CEO, initially dismissing healthcare leaders before serendipity shaped his path.His personal hospital-at-home experience after hip surgery confirmed that recovery is faster, cheaper, and better at home.Ambient AI, which auto-generates clinical notes, is the one decision at Michigan Medicine that faced almost no dissent.America's top-tier quaternary care leads the world; the real crisis is access, not quality.AI can address the clinician shortage in a year or two, something traditional training pipelines need decades to solve.About our Guest:Marschall S. Runge, M.D., Ph.D., was born in Austin, Texas, and graduated from Vanderbilt University with a BA in General Biology and a PhD in Molecular Biology. He received his medical degree from the Johns Hopkins School of Medicine and trained in internal medicine at Johns Hopkins Hospital. He was a cardiology fellow and junior faculty member at Massachusetts General Hospital. Dr. Runge's next position was at Emory University, where he directed the Cardiology Fellowship Training Program. He then moved to the University of Texas Medical Branch in Galveston, where he was Chief of Cardiology and Director of the Sealy Center for Molecular Cardiology. He joined the University of North Carolina (UNC) from 2000 – 2014, where he served as Charles Addison and Elizabeth Ann Sanders Distinguished Professor of Medicine, Chair of the Department of Medicine, President of UNC Physicians and Vice Dean for Clinical Affairs.Dr. Runge is the former CEO of Michigan Medicine and Dean of the University of Michigan Medical School, and a practicing cardiologist. Dr. Runge is board-certified in internal medicine and cardiovascular diseases and has spoken and published widely on topics in clinical cardiology and vascular medicine.At the University of Michigan, Dr. Runge began serving as the executive vice president for medical affairs in March 2015 and, in January 2016, he was also appointed as the dean of the Medical School. He is the first person to serve in this combined position created by the Regents for the purpose of strengthening the integration between the Medical School and health care delivery in our hospitals and health centers.During his tenure in these leadership roles, Dr. Runge has implemented transformative change and positioned Michigan Medicine and the Medical School for continued success. Notable achievements during this period include: a significant expansion of Michigan Medicine's clinical network in the state, through integration of two health systems, the former Metro Health in Grand Rapids and Sparrow Health System in Lansing, multiple joint ventures with Trinity Health, launch of the Precision Health Initiative, a major research collaboration with several other U-M schools and colleges; oversight of the conclusion of the Victors for Michigan campaign which raised $1.5 billion dollars for institutional strategic priorities; and the development and implementation of Michigan Medicine's first strategic plan for diversity, equity and inclusion in support of the broader university-wide DEI initiative.Under Dr. Runge's leadership, the University of Michigan Health's adult hospitals were ranked best in Michigan in 2023-2024 in U.S. News & World Report “Best Hospitals” rankings, the 31st consecutive year that U-M Health has been nationally recognized for strong across-the-board performance. In Newsweek's 2024 ranking of America's Best Hospitals, U-M Health ranked #1 in the state and #3 in the country.Current and new initiatives under Dr. Runge's leadership include construction of the The D. Dan and Betty Kahn Health Care Pavilion, a 12-story and 264 private room inpatient hospital; working to reduce faculty and staff burnout; executive rounding to help promote employee engagement and retention; establishment of the Heart Brain Institute and Global Health; oversight and development of the Anti-Racism Oversight Committee to help achieve an anti-racist culture; improved access and patient experience through the M2C2 Capacity Center; and the establishment of the Care at Home initiative which focuses on providing safe, hospital-level care to patients in their own home.Dr. Runge has been a physician-scientist for his entire career, combining basic and translational research with the care of patients with cardiovascular diseases and education. He is the author of over 200 publications in the field and holds five patents for novel approaches in health care.Links Supporting This Episode: Dr. Marschall Runge Website: CLICK HEREDr. Marschall Runge LinkedIn page: CLICK HEREThe Great Healthcare Disruption book link: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today's episode delves into the latest innovations and strategic shifts propelling the industry forward. A notable dialogue emerging in psychiatric drug development comes from TLDR Biotech's engagement with Shlomi Raz and Ken Belotsky, co-founders of Palomar Labs. This conversation heralds a transformative shift in psychiatric treatments, moving beyond traditional psychedelics toward novel approaches deeply rooted in human experience. Initially inspired by the therapeutic potential of psychedelics such as psilocybin, early research, notably from Johns Hopkins, sought to establish these compounds within a biopharmaceutical framework. Despite historical evidence supporting their efficacy, challenges persisted in reclassifying these Schedule I substances as viable therapies. Raz and Belotsky, pioneers in this initial psychedelic wave, now lead efforts at Palomar Labs to develop next-generation therapeutics targeting serotonin receptors without the hallucinogenic effects typical of classical psychedelics. This approach seeks to dismantle longstanding industry biases against specific receptor targets known as "anti-targets." A critical concept in their methodology is "neuroplastogens," as popularized by David Olson at UC Davis. These compounds are believed to induce beneficial neuroplastic changes without causing hallucinations. However, Palomar Labs exercises caution, viewing neuroplasticity not as a definitive biomarker for therapeutic efficacy but rather as one of many aspects to consider. Their unconventional "reverse" drug development model begins with anecdotal human experiences and is validated backward through preclinical animal models before advancing to clinical trials. This method relies on overlooked data sources—such as discarded trial reports and traditional medicine use cases—to uncover therapeutic candidates traditionally ignored due to biases against certain receptor targets. For example, they explore therapies for Parkinson's disease bypassing direct dopamine receptor modulation and treatments for Alzheimer's-related aggression avoiding heavily sedative antipsychotics. Palomar Labs' venture studio model emphasizes disciplined capital allocation and an unbiased approach to research outcomes. By prioritizing drug candidates with strong evidence from human experiences, they aim to swiftly advance promising therapies to proof-of-concept stages, readying them for further development by pharmaceutical partners or venture-backed entities. This paradigm shift from target-centric development to a model grounded in empirical human data represents a significant advancement in psychiatric drug discovery. In other industry news, Replimune has successfully navigated regulatory hurdles to secure FDA approval for its melanoma therapy, Tudriqev, following two prior rejections. This achievement underscores the resilience required in drug development and strategic regulatory engagement. The approval highlights the potential of oncolytic virus therapies—Tudriqev employs an innovative approach by using viruses to selectively infect cancer cells while sparing healthy tissue, simultaneously stimulating an immune response. Meanwhile, Eli Lilly continues its dominance in the obesity treatment market with Zepbound, despite new oral competitors. The enduring preference for injectable solutions highlights established efficacy and safety profiles that continue to resonate with healthcare professionals. In China, TransThera has gained regulatory approval for a bile duct cancer treatment, marking a significant step forward for Chinese innovation in oncology. Such advancements not only diversify treatment options but also elevate China's status as a pivotal contributor to global drug development. Challenges persist across the sector, exemplified by Fresenius Kabi's recall of a mislabeled morphine lot due to overdose risks. This incident underscores the vital importance of stringent quality control measures essential for patient safety. The biopharmaceutical landscape also sees Takeda securing FDA approval for its first-in-class orexin receptor agonist targeting narcolepsy—a testament to innovative approaches addressing unmet needs in sleep disorders. Amidst these developments, BioMarin has opted to terminate its $270 million rare disease asset following unsatisfactory Phase 3 results. Such decisions highlight the inherent risks within drug development pipelines and underscore the necessity for strategic flexibility. Leadership changes are shaping corporate trajectories too; BioNTech's appointment of Guido Oelkers as CEO exemplifies this trend. His experience will likely drive strategic realignments crucial for navigating complex industry challenges. Finally, the industry's focus on digital transformation is evident through Bausch + Lomb's partnership with VerilyMe—a collaboration aimed at enhancing dry eye education via digital and AI technologies. These stories collectively embody the dynamic nature of the pharmaceutical and biotech industries—where regulatory achievements, strategic pivots, and technological advancements are continuously redefining therapeutic landscapes and enhancing patient care worldwide. As we continue navigating this rapidly evolving field, staying informed on these developments is crucial for leveraging opportunities and addressing challenges within this innovative sector.Support the show

In his weekly clinical update, Daniel Griffin and Vincent Racaniello are distressed by Erica Schwartz' confirmation as CDC director, the GAO proposed pandemic preparedness plans, the national cyclospora outbreak and resulting two deaths, new screwworm and the scale of the Ebola outbreak in the Congo, and clear results from some of President Trump's policies dismantling public health activites including water safety, before Dr. Griffin deep dives into the measles outbreak, recent statistics on RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, FDA approval of Moderna's mRNA vaccine for seasonal flu, how to access and pay for Paxlovid, where to go for answers about long COVID-19, how SARS-CoV-2 infections may reactivate latent viral infections, particularly Aniello virus, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Senate confirms Erica Schwartz as CDC director (CIDRAP) PUBLIC HEALTH PREPAREDNESS: Experts Identified Actions to Improve Surveillance for Emerging Disease Threats (Government Accountability Office) Association Between First MMR Vaccination Before Age 2 Years and Childhood Autism in a U.S. EHR Cohort of 2.5 Million Children (The Pediatric Infectious Disease Journal) F.D.A. Approves Moderna's mRNA Flu Vaccine (NY Times) Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults (NEJM) Two Deaths Linked to Cyclosporiasis in Michigan (NY Times) CDC expands largest known cyclosporiasis outbreak to 15 states (Washington Post) Surveillance of Cyclosporiasis (CDC: Cyclosporiasis) Infectious DiseaseOutbreaks (Michigan: Health & Human Services) Cyclosporiasis Cases in North Carolina (North Carolina: Division of Public Health) Cyclospora Infection (Cyclosporiasis) (NYC Health) Missouri Communicable Disease Report (2026) (Missouri Health) Irrigation & Water Use (USDA: Economic Research Service) A Guide to OSHA's Field Sanitation Standard (OSHA) Turm purge at FDA and USDA triggers food safety 'brain drain' (FOODNavigator) Foodborne Illness Surveillance Systems (CDC) About Campylobacter infection (CDC: Campylobacter infection (Campylobacteriosis)) About Cyclosporiasis (CDC: Cyclosporiasis) About Listeria Infection (CDC: Listeria Infection (Listeriosis)) About Salmonella Infection (CDC: Salmonella Infection (Salmonellosis)) About Escherichia coli Infection (CDC: E.Coli Infection (Escherichia coli)) About Shigella Infection (CDC: Shigella-Shigellosis) About Vibrio Infection (CDC: Vibrio Infection (Vibriosis)) About Yersinia Infection (CDC: Yersinia Infection (Yersiniosis)) CDC Reveals Cause of Malaria's Return to US After 20 Years(Newsweek) Trump Dismantles USAID: Experts Say Move Will Help America's Rivals and Harm Millions (Newsweek) What we truly know about the huge US Cyclospora outbreak—and what we don't (CIDRAP) It's The Water, Not Produce, Likely Driving Cyclospora Outbreaks (Forbes) Dashboard SCREWWORM.Gov (USDA: Animal and Plant Health Inspection Service) CDC Activates Emergency Operations Center for New World Screwworm Response (CDC Newroom) Ebola dashboard (ebola.fyi) EBOLA: The Democratic Republic of the Congo, 2026(WHO) Bundibugyo virus disease outbreak Democratic Republic of the Congo (WHO: Democratic Republic of Congo) Ebola Outbreak: Current Situation (CDC:Ebola) EXCLUSIVE: Congo's Ebola epidemic started at least 4 months before it was detected (Science) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard (South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) Utah Measles Dashboard (Utah Department of Health and Human Services) Measles (VDH: Virginia Department of Health) Tracking Measles Cases in the U.S. (Johns Hopkins) HAP's Latest News Pa. Launches New Measles Dashboard (Hospital + HealthSystem Association of Pennsylvania) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) FDA vaccine advisers recommend adding subclade K to fall shots (CIDRAP) Moderna's mRNA flu shot mFlusiva snags FDA nod after refusal-to-file imbroglio (Fierece Pharma) Weekly surveillance report: clift notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Household Transmission of SARS-CoV-2 in Washington and Oregon, United States, 2022-2024 (Journal of the Pediatric Infectious Diseases Society) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Virus reactivation in acute and long COVID-19 (Nature) Reaching out to US house representative Letters read on TWiV 1346 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Students go back to school across Florida beginning August 10th. Undiagnosed hearing problems can cause problems for kids that manifest as behavorial issues in class. We speak with audiologist Dr. Courtney North with Johns Hopkins All Children's Hospital in St. Petersburg (FL). See omnystudio.com/listener for privacy information.

Primary care physician Lucy McBride has spent decades in a Washington, D.C. examination room doing something radical: listening. A Princeton and Harvard Med graduate who trained at Johns Hopkins, she built her career on the belief that health lives in the relationship between doctor and patient — not in the lab report. Her first book, Beyond the Prescription, lays out a four-quadrant framework for understanding the body as an ecosystem. In this conversation, we dig into why "normal" labs can be misleading, how AI and wearables are changing the game (and sometimes making things worse), the promise and pitfalls of GLP-1s, and what brain health prevention actually looks like. Lucy shares the appendicitis-bagel story that proves even doctors are imperfect patients. ▶ Subscribe YouTube @resaelewissmd 

Aging is non-negotiable, but cognitive decline is optional. Your brain isn't set in stone, it's a dynamic muscle capable of lifelong transformation. Through targeted lifestyle shifts in sleep, movement, diet, and stress management, you can physically grow your brain, reverse cognitive decline, and build a mind that gets stronger as you get older. In this episode, host Sharlee Dixon sits down with world-renowned neurologist and neuroscientist Dr. Majid Fotuhi. With over 35 years of experience, a PhD from Johns Hopkins, and medical training from Harvard, Dr. Fotuhi is a leading authority on neuroplasticity and Alzheimer's prevention. His award-winning work has been featured on CNN, NBC News, The Today Show, The New York Times, and The Washington Post. Together, they explore the science behind Dr. Fotuhi's new book, “The Invincible Brain: The Clinically Proven Plan to Age-Proof Your Brain and Stay Sharp for Life”. Dr. Fotuhi unpacks his revolutionary 12-week program, sharing how simple everyday habits, from Mediterranean eating and deep sleep to managing cortisol and even embracing boredom, boost blood flow, spur brain-derived fertilizer, and literally expand the memory center of your brain.   For more information about “The Invincible Brain: The Clinically Proven Plan to Age-Proof Your Brain and Stay Sharp for Life” by Dr. Majid Fotuhi, please visit: https://www.amazon.com/Invincible-Brain-Clinically-Proven-Age-Proof/dp/0063435713/ For more information about Dr. Fotuhi, please visit: https://drfotuhi.com For more information about The Invincible Brain App, please visit: https://invincible.drfotuhi.com Connect with Dr. Fotuhi on social media: On Instagram: https://www.instagram.com/dr_fotuhi/ On Linkedin: https://www.linkedin.com/in/majid-fotuhi-md-phd/ On YouTube: https://www.youtube.com/@DrFotuhi On Facebook: https://www.facebook.com/drmajidfotuhi

Back-to-school shopping includes shopping for backpacks. But what parents buy and how kids use them could contribute to problems including back pain. Gordon Byrd speaks with Dr. Brian Piazza, an orthopedic surgeon with Johns Hopkins All Children's Hospital in St. Petersburg. See omnystudio.com/listener for privacy information.

What happens when a physician publicly challenges government policy during a national health crisis? Johns Hopkins-trained emergency physician Dr. Ron Elfenbein joins Michael Jaco to share his firsthand account of treating thousands of COVID-19 patients, building one of the largest monoclonal antibody treatment programs in Maryland, and the legal battle that followed after he publicly criticized the federal pandemic response. Dr. Elfenbein discusses why he believed monoclonal antibodies should have played a much larger role in treating COVID-19, why he spoke out publicly, and why he believes he became the target of an unprecedented Department of Justice prosecution. In this powerful conversation, Dr. Elfenbein discusses: • His experience treating COVID-19 patients throughout the pandemic • Why he believes monoclonal antibody therapy was underutilized • Speaking publicly about pandemic policy and appearing on Fox News • His federal prosecution and subsequent acquittal • Why the Department of Justice appealed after the trial judge set aside the verdict • The broader implications for physicians, scientific debate, and free speech • Lessons America should learn before the next public health emergency Dr. Elfenbein also explains why he believes open scientific discussion, good-faith medical judgment, and protecting physicians from political retaliation are essential for improving future pandemic responses. Whether you're interested in medicine, public policy, or constitutional rights, this conversation raises important questions about science, free speech, and the relationship between medicine and government. Support Dr. Ron Elfenbein

In his weekly clinical update, Daniel Griffin and Vincent Racaniello discuss the numerous attempts by states to roll back vaccine laws, the recent surge of Dengue virus cases in Sri Lanka, the national cyclospora outbreak, new screwworm and Legionnaires cases, launching of the CHaT-Ox Ebola vaccine trail, scale of the Ebola outbreak in the Congo and if cross-reactive Ebola antibodies are effective, before Dr. Griffin deep dives into the measles outbreak including the new Pennsylvania dashboard, recent statistics RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, how to access and pay for Paxlovid, where to go for answers about long COVID-19, how long COVID and ME/CFS differ and contacting your federal government representative to stop the assault on science and biomedical research.   Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Dozens of States Tried to Roll Back Vaccine Laws. Here's How They Fared. (NY Times) Dengue cases in Sri Lanka surge past 80,000 (Newswire) After withdrawing false-positive test, FDA says Taylor Farms lettuce still a focus of Cyclospora investigation (CIDRAP) A difficult-to-trace parasite, messaging missteps contribute to summer of overwhelming Cyclospora outbreaks (CIDRAP) Surveillanceof Cyclosporiasis (CDC: Cyclosporiasis) Infectious DiseaseOutbreaks (Michigan: Health & Human Services) Cyclosporiasis Cases in North Carolina (North Carolina: Division of Public Health) Cyclospora Infection (Cyclosporiasis) (NYC Health) Legionnaires' Disease (NYC Health) MAP UPDATE: 50 buildings in Manhattan outbreak zone test positive for live bacteria (NBC: News) Dashboard SCREWWORM.Gov (USDA: Animal and Plant Health Inspection Service) CDC Activates Emergency Operations Center for New World Screwworm Response (CDC Newroom) Ebola dashboard (ebola.fyi) EBOLA:The Democratic Republic of the Congo, 2026 (WHO) Bundibugyo virus disease outbreak Democratic Republic of the Congo (WHO: Democratic Republic of Congo) Ebola Outbreak: Current Situation (CDC:Ebola) First volunteer vaccinated in the world's first Bundibugyo ebolavirus vaccine trial (University of Oxford) Cross-Reactive Bundibugyo Antibody Responses after Receipt of Licensed Ebola Vaccines (NEJM) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard (South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) UtahMeasles Dashboard (Utah Department of Health and Human Services) Measles (VDH: Virginia Department of Health) Tracking Measles Cases in the U.S. (Johns Hopkins) HAP's Latest News Pa. Launches New Measles Dashboard (Hospital + HealthSystem Association of Pennsylvania) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) FDA vaccine advisers recommend adding subclade K to fall shots (CIDRAP) Weekly surveillance report: cliff notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Impact of Nirsevimab in Its Second Season on Respiratory Syncytial Virus and Non-RSV Admissions in Children Under 5 (Pediatric Infectious Disease Journal) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Remdesivir and All-Cause Graft Loss Among Kidney Transplant Recipients With Symptomatic COVID-19 (JAMA: Network Open) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) Skeletal muscle properties in long COVID and ME/CFS differ from those induced by bed rest (Nature Communications) Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms (eBioMedicine) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1344 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Glenn sits down with political scientist Steven Teles of Johns Hopkins to discuss one of higher education's most stubborn problems: ideological homogeneity. University faculties lean dramatically further left than the broader population, and in some humanities and social science disciplines, the imbalance has become self-reinforcing — conservatives self-censor or don't enter the field at all, […]

Most people think of the gut as a digestive organ. It is not. It is the upstream controller of your metabolism, immune function, brain health, skin, and hormones and almost everyone is running it on a depleted, misfed microbiome without knowing it.Dr. Colleen Cutcliffe, PhD is the co-founder and CEO of Pendulum Therapeutics, holds a PhD in biochemistry from Johns Hopkins, and spent over 15 years in pharma and biotech before pioneering next-generation probiotic science. Her team was the first in the world to manufacture Akkermansia, a strain found at high levels in virtually every centenarian population studied and depleted in almost every major chronic disease. What makes this conversation different from most gut health discussions is the level of scientific rigor behind it. This is not wellness theory. This is published research, clinical data, and a decade of actually building the science from the ground up.Join the most comprehensive *female-specific community for health and longevity optimization.* After over a decade dedicated to human performance and women's health, I created this space to share everything you need to know to optimize health and lifespan. Inside, you'll get access to exclusive protocols, live Q&As, the latest female longevity science, and a private, supportive community of like-minded women.https://kayla-barnes-lentz.circle.so/checkout/become-a-memberIn this conversation we explore:How your gut produces its own GLP-1 naturally and why synthetic versions may blunt that system over timeWhy Akkermansia is elevated in centenarians and depleted across virtually every chronic diseaseThe fiber gap: 95% of people are under-threshold and it is driving metabolic and colon health declineWhat early antibiotic use does to the microbiome and how to rebuild at any ageWhy soap may be fueling the allergy and asthma epidemic by stripping the skin's protective barrierHow butyrate links gut health, colon cancer risk, and natural GLP-1 productionWhy most probiotics on Amazon do not contain what the label claimsConnect with Kayla:Instagram: https://www.instagram.com/kaylabarnes/TikTok: https://www.tiktok.com/@femalelongevityTwitter:https://x.com/femalelongevityWebsite:https://www.kaylabarnes.com/Spotify: https://open.spotify.com/show/4OLWWn22RGB0argbRPvAaQ?si=8e91b3c9e0ce4054Apple: https://podcasts.apple.com/us/podcast/longevity-optimization-with-kayla-barnes-lentz/id1591130227Follow Her Female Protocol: https://www.protocol.kaylabarnes.comLearn more about Dr ColeenInstagram: https://www.instagram.com/drcolleencutcliffe/Pendulum Life Instagram: https://www.instagram.com/pendulumlifeco/Website: https://pendulumlife.com/

Schools open the week of August 10th across most of Florida. That means getting kids back on a sleep schedule after the long summer break. We speak with pediatric sleep expert Dr. Luis Ortiz of Johns Hopkins All Children's Hospital in St. Petersburg about dealing with kids and the alarm clock. See omnystudio.com/listener for privacy information.

Johns Hopkins political scientist Yascha Mounk joined Bret Stephens to discuss his new essay, “Censorship Won't Help the Jews,” in the (Fixing) America issue of SAPIR.Read Yascha's essay here: https://sapirjournal.org/fixing-america/2026/censorship-wont-help-the-jews/Questions or comments? Send us a note at ⁠info@sapirjournal.org⁠Music from #Uppbeat: ⁠https://uppbeat.io/t/theo-gerard/monsieur-groove

Cheryl Sew Hoy, CEO of Tiny Health, built a gut microbiome testing platform from her living room with a newborn, a toddler, and a co-founding spouse. In this episode, she shares the real mechanics of scaling a science-driven health company while designing a support system that actually works.- Validated market demand by testing search keywords around baby eczema and allergies, then used those insights to shape paid and organic channel strategy across Google and Meta- Built scientific credibility by recruiting advisors from Mayo Clinic, Johns Hopkins, and UCSF to fill expertise gaps and establish trust in a category where consumers and doctors alike lacked awareness- Negotiated explicit division of labor at home and hired family members into operational roles, creating a sustainable structure that protected founder bandwidth through three children and a four-times revenue growth yearListen on Apple Podcasts, Spotify, or Amazon Music. Follow Sales Talk for CEOs so you never miss an episode.

Step into the crucial world of neonatal care with this episode of Legal Nurse Podcast, hosted by Pat Iyer and featuring neonatal nurse practitioner and expert witness Yana Felix. As medical knowledge and parental expectations continue to evolve, the first moments of a newborn's life are both medically and legally complex. Yana Felix, who practices at Johns Hopkins, shares clinical insights and legal pearls drawn from hands-on experience in newborn resuscitation, delivery room challenges, and the nuanced standards of care shaping today's neonatal outcomes. Together, discuss the foundational steps in newborn care, the critical reasoning behind interventions like vitamin K administration, and the intricacies of Apgar scoring. The conversation navigates real-world dilemmas such as parental refusal of standard treatments and the shifting recommendations of the Neonatal Resuscitation Program (NRP), offering valuable guidance for clinicians, legal nurse consultants, and attorneys who may one day analyze these cases. Whether you are a healthcare professional, legal expert, or a parent interested in understanding what happens in those vital first minutes of life, this episode will provide you with practical knowledge and a deeper appreciation for both the science and the stakes of neonatal care. What You'll Learn in This Episode on Vitamin K Refusals, Documentation Gaps, and Litigation Risks in Neonatal Care Here are 5 discussion questions answered in the podcast: Why is vitamin K administration at birth controversial among some parents, and what are the medical implications of refusing it? How are Apgar scores used to assess a newborn's health, and what red flags should be noted in medical records during legal reviews? What are the key updates from the 9th Edition of the Neonatal Resuscitation Program (NRP), and how do they impact clinical practice? How does delayed cord clamping benefit newborns, and what are the potential risks if not properly balanced with timely interventions? In what ways might documentation or lack thereof influence the legal outcomes of neonatal resuscitation cases? Get the free transcripts and also learn about other ways to subscribe. Go to Legal Nurse Podcasts subscribe options by using this short link: http://LNC.tips/subscribepodcast. https://youtu.be/GVsR5EOrJVU Your Presenter for Vitamin K Refusals, Documentation Gaps, and Litigation Risks in Neonatal Care Pat Iyer Pat Iyer is a seasoned legal nurse consultant and business coach, renowned for her expertise in guiding new legal nurse consultants to successfully break into the field. As the host of the Legal Nurse Podcast, Pat addresses critical challenges that legal nurse consultants face, such as difficulty in landing clients and a lack of response from attorneys. Through her insightful episodes, she emphasizes the importance of effectively communicating one's value to potential clients. With a wealth of experience, Pat has empowered countless consultants to overcome these hurdles and thrive in their careers. Connect with Pat Iyer by email at patiyer@legalnusebusiness.com Yana Felix Yana is a Neonatal Nurse Practitioner at Johns Hopkins Hospital, where she provides expert clinical care for critically ill newborns. She also serves as a Neonatal Nurse Practitioner legal consultant, sharing clinical knowledge for medicolegal review and education. When she is not on this podcast, Yana is enjoying art history, traveling, and exploring the world with her canine companion. Connect with Yana Felix by email at yfelix1@jh.edu

Send us Fan MailThis week I am delighted to finally bring you the interview I did with Dr Michael T Myers Jr MD about vaccines.Just to let you know who he is;Dr. Michael T. Myers Jr., MD was the Chief of Primary Care, Pediatrics, and Practice Transformation for Summit Health New Jersey, one of the state's largest medical groups, before he retired in 2025. A physician leader with more than 35 years of experience in medical group practice management, public health initiatives, and health care consulting, Dr. Myers has held leadership positions at Partners HealthCare in Boston (now Mass General Brigham), Blue Cross Blue Shield of Massachusetts, and PricewaterhouseCoopers. During the COVID-19 pandemic, he served as COVID-19 scientific consultant to Stonehill College in Easton, Massachusetts, and was appointed Adjunct Lecturer.His first book, COVID-ology: A Field Guide [CRC Press |2022], is an academic title for college health and science majors, was released in December 2022. Dr. Myers completed his primary care residency at Mount Auburn Hospital in Cambridge, Massachusetts, and received his MD from Harvard, BA from Johns Hopkins, and MBA from Northeastern University. He is now the author of "The Vaccine Bible" an absolute must-have for anyone even remotely interested in kid's health, vaccines and general health.We are talking EVERYTHING to do with vaccines.Why the vaccine schedule is what it is (Why are there soo many shots??)What vaccines really are, and what they do.What are measles and why is there a flare-up in the number of cases.Why we see an uptick in the number of vaccine hesitant people? How do you asses the risk of a vaccine Vs the risk of an illness?and much, MUCH more.As I've been saying on the podcast for weeks, I had a great conversation with him on this and am delighted that I'm able to release this just before his book gets published (tomorrow!) You can buy the Vaccine Bible at all your good bookstores, just go click on this link (The ebook is an absolute insane bargain!)Or head to AmazonBarnes and NobleBookshopAs always; HPNB still only has 5 billing cycles.So this means that you not only get 3 months FREE access, no obligation! BUT, if you decide you want to do the rest of the program, after only 5 months of paying $10/£8 a month you now get FREE LIFE TIME ACCESS! That's $50 max spend, in case you were wondering.Though I'm not terribly active on  Instagram and Facebook you can follow us there. I am however active on Threads so find me there! And, of course, you can always find us on our YouTube channel if you like your podcast in video form :) Visit healthypostnatalbody.com and get 3 months completely FREE access. No sales, no commitment, no BS. Email peter@healthypostnatalbody.com if you have any questions, comments or want to suggest a guest/topic Playing us out this week, more Dresden the Flamingo 

Expert en mycologie, Antoine Alibert étudie les champignons médicinaux depuis plus de 15 ans. Il s'appuie sur les recherches scientifiques les plus récentes et sur des traditions millénaires venues d'Asie pour mieux comprendre le potentiel thérapeutique de ces organismes, aujourd'hui au cœur des travaux de laboratoires comme Johns Hopkins, Harvard ou l'Imperial College London.Il explique :◼️ Pourquoi Harvard et Johns Hopkins s'intéressent autant aux champignons médicinaux.◼️ Ce que la science sait vraiment sur le Lion's Mane, le Cordyceps, le Reishi, le Shiitake, le Maïtaké et le Chaga.◼️ Pourquoi 90 % des compléments à base de champignons ne tiennent pas leurs promesses.◼️ Ce que les recherches révèlent sur les champignons psychédéliques et leur potentiel thérapeutique.◼️ Comment choisir un complément vraiment efficace et éviter les pièges.

In his weekly clinical update, Daniel Griffin and Vincent Racaniello explore the source/not source of the national cyclospora outbreak, trust in the FDA to correctly identify the source, new screwworm, Legionnaires and cyclosporasis cases, the Ebola outbreak in the Congo and development of a novel vaccine and antiviral before Dr. Griffin deep dives into the measles outbreak including the new Pennsylvania dashboard, recent statistics RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, difference between high and standard dose influenza vaccines, how to access and pay for Paxlovid, where to go for answers about long COVID-19, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode How helpful is not up to date? CDC: cyclosporiasis Taylor Farms pulls Mexican Lettuce on Cyclospora Cases (Bloomberg) FDA retracts positive cyclospora test on Taylor Farms lettuce (NPR: WHYY) False-positive lab sample DOES NOT change the basis for FDA's ongoing outbreak investigation (X) FDA retracts test result but still links Taylor Farms lettuce to cyclosporiasis (Washington Post) Infectious Disease Outbreaks (Michigan: Health & Human Services) Cyclospora Infection (Cyclosporiasis) (NYC Health) Legionnaires' Disease (NYC Health) Chapter 8: Cooling Towers (NYC Health) You can verify ifa person is licensed on the New York State Office of the Professions website: (NSPE-NY) Board for global EHS Credentialing (American Board of Industrial Hygiene) Water treatment vendor (Association of Water Technologies) Cooling Towers: Information for Owners and Operators (NYC Health) Dashboard SCREWWORM.Gov (USDA: Animal and Plant Health Inspection Service) CDC Activates Emergency Operations Center for New World Screwworm Response (CDC Newroom) Ebola dashboard (ebola.fyi) EBOLA:The Democratic Republic of the Congo, 2026(WHO) Bundibugyo virus disease outbreak Democratic Republic of the Congo(WHO: Democratic Republic of Congo) Ebola Outbreak: Current Situation (CDC:Ebola) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard (South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) UtahMeasles Dashboard (Utah Department of Health and Human Services) Measles (VDH: Virginia Department of Health) Tracking Measles Cases in the U.S. (Johns Hopkins) HAP's Latest News Pa. Launches New Measles Dashboard (Hospital + HealthSystem Association of Pennsylvania) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles(CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Measles(CDC: Measles Rubeola) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) FDA vaccine advisers recommend adding subclade K to fall shots (CIDRAP) Influenza vaccine effectiveness against outpatient acute respiratory illness withlaboratory-confirmed influenza, United States, 2024–25 season (CID) Effect of high-dose versus standard-dose influenza vaccines on hospitalisation outcomes and mortality in older adults: a systematic review and meta-analysis (LANCET: Healthy Longevity) Weekly surveillance report: clift notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Randomized, Double-Blind, Placebo-Controlled First-in-Human Trial of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem Helix (JID) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) UnderstandingCoverageOptions (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1342 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

In this episode of Shift AI, Noah Smith, Vice Provost for AI at the University of Washington and Senior Director of NLP Research at the Allen Institute for AI, joins host Boaz Ashkenazy for a wide ranging conversation on how universities are preparing for a workplace increasingly run by AI agents.Noah's path wound from a PhD at Johns Hopkins to a tenured professorship at Carnegie Mellon, until a call from UW pulled him west in 2015 to help build out its natural language processing faculty. A few years later he took on a second role leading a research team at the Allen Institute for AI, and this past November added a newly created role as UW's first Vice Provost for AI. The conversation covers how faculty across UW are experimenting with AI in the classroom, from an interactive logic textbook in the philosophy department to new AI literacy courses, and digs into OLMo, the fully open language model project Noah leads at Ai2, unpacking why releasing the weights, code, and training data together, not just an API, matters for regulated industries, universities, and anyone who wants to retrain a model rather than just prompt it.Noah lays out a scenario where 80 percent of entry level work gets done by autonomous agents and argues the skill universities need to double down on is not AI literacy so much as discernment, the ability to unwrap a problem and figure out what questions to ask.This one is for university administrators, provosts, and faculty grappling with AI policy, as well as founders and engineers building on open source models, and anyone curious how a major research university is trying to get ahead of the agentic era instead of just reacting to it.Chapters[00:05] Welcome to Shift AI, live from UW's Foster School of Business[03:44] Noah's path from Carnegie Mellon to UW's Vice Provost for AI[06:08] Bagging groceries: Noah's first paid job[08:11] Six months in: what surprised Noah most about the role[09:22] How AI is reshaping teaching and pedagogy at UW[11:33] Preparing students for a world where agents do 80 percent of the work[14:08] Inside the Allen Institute for AI and the origins of OLMo[15:52] What "fully open" really means for language models[17:49] Specialized models versus general-purpose models for regulated industries[19:47] AI governance, security, and UW's new governance committee[24:35] The future of work in two words: human agencyConnect with Noah SmithLinkedIn: https://www.linkedin.com/in/noah-smith-0322511a4/Connect with Boaz AshkenazyLinkedIn: https://www.linkedin.com/in/boazashkenazy/Email: info@shiftai.fm

Tech News and Commentary Dave and Chris discuss Microsoft's latest layoffs, Xbox becoming independent, a new authentication system, Meta using Ai for layoffs, and more. “News Pick of the Week” with Ralph Bond World leading medical research institutions, such as Johns Hopkins, are advancing the field of psychedelic medicine to help treat PTSD and depression. […]

Our guest today is Vickie Antolini, Senior Client Partner, Global Education Practice at Korn Ferry, a major consultancy specializing in Academic Leadership Search. Vickie specializes in the recruitment of Presidents, Provosts, Deans of professional schools, with an emphasis in business education, as well as senior level functional administrators in finance, operations, human resources, and compliance.Vickie has completed leadership engagements for such prestigious institutions as Johns Hopkins, Penn, Columbia, UCLA, Duke, Cornell and many others. With a professional and personal interest in the promotion and advancement of female leaders, Victoria was a panelist and featured speaker for the 2020 Johns Hopkins University Mary Elizabeth Garrett Executive Leadership for Women Faculty seminar.In this timely discussion, Vickie brings us up to speed on current trends in academic executive search, touching upon many topics including:• Getting into the search process • Interviewing tips • Working with a search consultant • Understanding search committees • Changing expectations  • Why you, why now, and when them?  • Standard interview questions a prospective dean may encounterLearn more about Vickie Antolini.Comments/criticism/suggestions/feedback? We'd love to hear it. Drop us a note.Thanks for listening.-Produced by Joel Davis at Analog Digital Arts--DEANS COUNSEL: A podcast for deans and academic leadership.James Ellis | Moderator | Dean of the Marshall School of Business at the University of Southern California (2007-2019)David Ikenberry | Moderator | Dean of the Leeds School of Business at the University of Colorado-Boulder (2011-2016)Ken Kring | Moderator | Co-Managing Director, Global Education Practice and Senior Client Partner at Korn FerryDeansCounsel.com

A Navy veteran was convicted of a felony after refusing to wear a face mask while observing ballot counting during the 2024 election. Tim Hazelo says the conviction caused him to lose his security clearance and his defense contracting job. He is appealing the conviction while also running for the state House in Washington's 10th Legislative District. Steve Cortes joins to discuss his new documentary which argues political leadership and government mismanagement drove both the Pacific Palisades wildfire and the stalled rebuild. Joe Winston, CEO of NET Recovery, speaks on the FDA-cleared neurostimulation device that he says can manage opioid withdrawal symptoms without pharmaceuticals. Steve Cortes is a former 25-year Wall Street bond trader and has appeared on Fox News, CNN, and CNBC, and led Hispanic voter outreach for the Trump campaign. His new documentary is “Palisades Fire: Newsom's Nightmare.” Follow at https://x.com/cortessteve Tim Hazelo is a retired U.S. Navy veteran whose service spanned Desert Shield/Desert Storm and counter-narcotics missions across South and Central America. Now a defense contractor training combat aircrews at NAS Whidbey Island, he has also served two terms as Chair of the Island County Republican Party and is now its State Committeeman. Follow at https://x.com/TNTT_Hazelo Joe Winston is the founder and CEO of NET Recovery, maker of a non-invasive neurostimulation device for opioid withdrawal and addiction recovery. He holds an MS in Engineering from the University of Pennsylvania and a BEng from Johns Hopkins. Learn more at https://relief.netrecovery.net/ 「 SUPPORT OUR SPONSORS 」 • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/fatty15⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/paleovalley⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twc.health/drew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • CHAPTER - For free and unbiased Medicare help, dial (218) 521-2472 to speak with my trusted partner, Chapter, or go to ⁠⁠⁠⁠⁠https://askchapter.org/drdrew⁠⁠⁠⁠⁠ Chapter and its affiliates are not connected with or endorsed by any government entity or the federal Medicare program. Chapter Advisory, LLC represents Medicare Advantage HMO, PPO, and PFFS organizations and stand alone prescription drug plans that have a Medicare contract. Enrollment depends on the plan's contract renewal. While we have a database of every Medicare plan nationwide and can help you to search among all plans, we have contracts with many but not all plans. As a result, we do not offer every plan available in your area. Currently we represent 50 organizations which offer 18,160 products nationwide. We search and recommend all plans, even those we don't directly offer. You can contact a licensed Chapter agent to find out the number of products available in your specific area. Please contact Medicare.gov, 1-800-Medicare, or your local State Health Insurance Program (SHIP) to get information on all of your options. 「 ABOUT THE SHOW 」 This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://kalebnation.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Susan Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/firstladyoflove⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Content Producer • Emily Barsh - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/emilytvproducer⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

— What if one of the most powerful tools for improving your health was already at your fingertips? In this episode, we explore the fascinating intersection of artificial intelligence and personal well-being through the themes of Better Health with AI: Your Roadmap to Results with Dr. Earl Campazzi. As AI rapidly transforms the way we live and work, it is also changing how we understand, monitor, and care for our health. Dr. Earl discuss how emerging technologies—from wearable devices and health apps to genetic insights and AI-powered analysis—can help us move from reactive healthcare to proactive wellness. How can we detect health risks earlier? Make more personalized decisions about nutrition, exercise, and longevity? And how do we use these tools wisely while remaining aware of their limitations? Join us for an insightful conversation about the future of preventive medicine, the promise and pitfalls of AI, and how technology can empower us to take a more active role in creating healthier, longer, and more vibrant lives. Valeria sits with Dr. Earl J. Campazzi, Jr — He is the author of  "Better Health with AI: Your Roadmap to Results." Dr. Earl J. Campazzi, Jr., brings over 35 years of clinical experience and four board certifications to his Palm Beach Concierge Practice, bridging traditional medicine with modern technology. A graduate of the University of Pittsburgh School of Medicine, he also holds three degrees from Johns Hopkins University—including a Master of Public Health from the School of Hygiene and Public Health—and an MBA from Duke University. Dr. Campazzi's distinguished career includes serving as Senior Associate Consultant at the Mayo Clinic, Chief Resident in Preventive Medicine at Johns Hopkins, and Medical Director for Palm Beach County's Occupational Health Clinic. As founder of Island Medical Care, he has practiced concierge medicine in Palm Beach since 2006, earning national recognition such as HCA's Top Physician for Patient Satisfaction award, while maintaining staff privileges at leading hospitals including Cleveland Clinic Florida. Passionate about making artificial intelligence accessible to everyone—even those who aren't "tech people"—Dr. Campazzi helps families use simple, practical tools to live longer, healthier lives. Learn more about Dr. Earl J. Campazzi, Jr and his work!

We've been told for decades that giving testosterone to a man with prostate cancer is like throwing gasoline on a fire. But what if, in the right context, it actually acts as the extinguisher?” It sounds like medical heresy, yet this is the foundation of Bipolar Androgen Therapy (BAT). Imagine a treatment that intentionally cycles your hormones from extreme highs to extreme lows to "overload" cancer cells and reset their sensitivity to medicine.In this episode, we sit down with a true pioneer of this paradigm shift: Dr. Michael Schweizer. An Associate Professor at the Fred Hutchinson Cancer Center and a key architect behind the original BAT trials at Johns Hopkins, Dr. Schweizer is the scientist moving the bar for men with advanced, castrate-resistant disease. We're moving past the fear-based dogma to look at the clinical data that proves supraphysiologic testosterone isn't just a quality-of-life booster—it's a sophisticated weapon against resistant tumors.In this episode, you'll learn:The "Hormone Shock" Mechanism: How flooding the body with 1,500+ ng/dL of testosterone causes "mitotic catastrophe" in cancer cells adapted to low-androgen environments.The Resensitization Secret: Why cycling BAT can actually "reset" your cancer, making drugs like Enzalutamide work again after they've failed.Precision Selection: Which specific genetic mutations (like TP53) might predict who becomes an "exceptional responder" to high-dose testosterone.The Sequential Strategy: Why the order of your treatments—BAT first, then RPIs—could potentially extend survival by nearly 10 months.⏱️ Chapters00:00 Introduction: Can Testosterone Treat Prostate Cancer? 02:00 The surprising origin of Bipolar Androgen Therapy (BAT) 04:10 ⭐ Stop & Watch: Why Charles Huggins hinted at this decades ago 07:10 Why ordinary testosterone therapy failed—and BAT didn't 08:20 ⭐ Stop & Watch: The BAT protocol explained (400 mg every 28 days) 10:00 Why BAT is only used in castration-resistant prostate cancer 14:05 ⭐ Stop & Watch: The TRANSFORMER trial—did BAT actually work? 16:20 ⭐ Stop & Watch: How BAT may make failed treatments work again 20:30 ⭐ Stop & Watch: If testosterone isn't the enemy...why do we suppress it? 22:10 ⭐ Must Watch: The biology that completely changes how we think about testosterone 24:10 How BAT damages cancer DNA 26:30 BAT, quality of life, and survival—what the evidence really shows 30:00 ⭐ Stop & Watch: The sequencing strategy that could add months of cancer control 31:30 Which patients may respond best to BAT? 33:20 ⭐ Must Watch: Why every advanced prostate cancer patient should consider genetic testing 36:00 Can someone on ADT simply start testosterone? 40:00 Where BAT fits among today's prostate cancer treatments 43:00 ⭐ Stop & Watch: BAT + Lutetium PSMA—the next frontier 45:00 How to find BAT clinical trials 47:00 Should hormone therapy ever be stopped? 53:00 Final thoughts____________________________________

Duration: 1 hr In this episode of Bright Spots in Healthcare, host Eric Glazer brings together leaders from Johns Hopkins Medicine, Northwell Health, WVU Medicine, and TytoCare to explore one of healthcare's biggest challenges: how to move beyond isolated AI pilots and operationalize AI in ways that genuinely improve specialty care. While AI continues to dominate headlines, the organizations making the greatest progress aren't simply adopting more technology. They're redesigning workflows, strengthening governance, extending specialist expertise, and embedding AI into clinical operations in ways that improve patient access while reducing burden on clinicians. This discussion explores what it really takes to scale AI across complex health systems, from executive strategy and governance to workflow redesign, remote examinations, ambient AI, and extending specialty expertise into rural and underserved communities. Our guests include: Rebecca Canino, MBA, Executive Director, Office of Telemedicine, Johns Hopkins Medicine Kristin Myers, Executive Vice President & Chief Digital Officer, Northwell Health Sharda Udassi, MD, Professor, Pediatric Hospital Medicine Division & Associate Chief Quality Officer, WVU Medicine Greg Orr, Chief Operating Officer, TytoCare Together, they explore: Why successful AI initiatives begin with operational transformation—not technology deployment How leading health systems are embedding AI into existing clinical workflows instead of creating new ones What governance looks like when organizations are scaling AI responsibly How remote examinations and AI are helping extend scarce specialty expertise into rural and community settings Practical examples of AI improving diabetic retinopathy screening, patient navigation, scheduling, EEG interpretation, and specialty access Why redesigning care delivery—not simply adding digital tools—is becoming the key to sustainable AI adoption Where healthcare leaders see the next generation of AI creating measurable impact for clinicians and patients alike. Whether you're leading digital transformation, telehealth, clinical operations, or AI strategy, this episode offers practical lessons from organizations moving beyond experimentation and successfully scaling AI across specialty care. Panelist Bios: https://www.brightspotsinhealthcare.com/events/scaling-ai-enabled-remote-specialty-care-from-innovation-to-operational-performance/ Download the Episode Guide: Get key takeaways and expert highlights to help you apply lessons from the episode. Download guide: https://www.brightspotsinhealthcare.com/wp-content/uploads/2026/07/Episode-Guide-Bright-Spots-in-Health-Care-TytoCare-07-15-26.pdf  Key Insights Summary: Find key insights from the discussion, guest takeaways, and detailed moderator notes captured by Eric during the conversation, https://www.brightspotsinhealthcare.com/wp-content/uploads/2026/07/Key-Insights-Summary-Bright-Spots-07-15-26.pdf   Thank You to Our Episode Partner, TytoCare: TytoCare is helping health systems rethink how specialty care is delivered beyond the traditional walls of the hospital and clinic. Through its AI-enabled, FDA-cleared remote examination platform, TytoCare equips clinicians with clinical-grade exam data from virtually anywhere, enabling more informed decision-making than video visits alone. By combining guided remote examinations with AI-assisted workflows, TytoCare helps provider organizations improve access to specialty care, optimize clinician capacity, strengthen virtual care models, and create more connected patient experiences. As health systems look to scale AI responsibly, TytoCare is helping turn innovation into operational performance. Schedule a Meeting with a Senior Leader at TytoCare: Interested in learning how leading health systems are scaling remote specialty care?  To connect with Greg Orr or another member of the TytoCare leadership team, contact show producer Jessica Tenzer at jtenzer@brightspotsventures.com to schedule a conversation. About Bright Spots Ventures: Bright Spots Ventures is a healthcare strategy and engagement company that creates content, communities, and connections to accelerate innovation. We help healthcare leaders discover what's working, and how to scale it. By bringing together health plan, hospital, and solution leaders, we facilitate the exchange of ideas that lead to measurable impact. Through our podcast, executive councils, private events, and go-to-market strategy work, we surface and amplify the "bright spots" in healthcare, proven innovations others can learn from and replicate. At our core, we exist to create trusted relationships that make real progress possible. Visit our website at www.brightspotsinhealthcare.com.

Ari Miller is the founder of ASM Performance and a Certified Mental Performance Consultant who helps athletes, coaches, executives, and organizations perform more consistently under pressure. Miller began his career as a college basketball coach, serving on staff at St. Michael's College, Bryant University, and the University of Vermont. He brings more than 15 years of experience in college athletics as a coach, administrator, counselor, and performance specialist. Miller has developed and led mental health, leadership, and performance programs at several NCAA institutions, including Vermont and Johns Hopkins. In 2024, he began working with New York University Athletics as a mental performance consultant for its student-athletes and coaches. Through individual coaching, team workshops, and leadership development, Miller provides practical, evidence-based strategies designed to strengthen confidence, focus, resilience, and sustained high performance.On this episode Mike and Ari discuss why physical preparation is essential for athletic success, so too is the mental preparation that athletes must undertake. Throughout our conversation, we explore the intricate relationship between mental resilience and athletic performance, delving into strategies that foster confidence, focus, and composure under pressure. Miller shares invaluable insights gleaned from his work with athletes, coaches, and organizations, illustrating how tailored mental performance strategies can lead to sustained high performance. Cultivating a strong mindset is not merely advantageous but essential for those striving to excel in the competitive arena of basketball.Follow us on Twitter and Instagram @hoopheadspod for the latest updates on episodes, guests, and events from the Hoop Heads Pod.Make sure you're subscribed to the Hoop Heads Pod on Apple, Spotify, or wherever you get your podcasts and while you're there please leave us a 5 star rating and review. Your ratings help your friends and coaching colleagues find the show. If you really love what you're hearing recommend the Hoop Heads Pod to someone and get them to join you as a part of Hoop Heads Nation.Grab your notebook before you listen to this episode with Ari Miller, founder of ASM Performance.Website - https://www.asmcoach.com/Email - coacharimiller@gmail.comInstagram - https://www.instagram.com/arimillercmpcVisit our Sponsors!Give With HoopsGive With Hoops is a groundbreaking initiative that fuses basketball analytics with modern sponsorship. Built for teams who see data as opportunity, from AAU programs to college powerhouses. By tying on-court performance directly to community and sponsor engagement, Give With Hoops help programs raise more while deepening support from those who believe in the game.D3 Direct Recruiting PlaybookHoop Heads Listeners currently get 25% off!Your step-by-step guide to getting recruited as a college athlete at the NCAA Division 3 level. This course is designed by former D3 Athletes to take you from zero interest from college coaches to securing your first offer and putting you on the path to committing.The Coaching PortfolioYour first impression is everything when applying for a new coaching job. A professional coaching portfolio is the tool that highlights your coaching achievements and philosophies and, most of all, helps separate you and your abilities from the other applicants. Special Price of just $25 for all Hoop Heads Listeners.Wealth4CoachesEmpowering athletic coaches with financial education, strategic planning, and practical tools to build lasting wealth—on and off the court.If you listen to and love the Hoop Heads Podcast, please consider giving us a small tip that will help in our quest to become the #1 basketball coaching podcast. https://hoop-heads.captivate.fm/supportTwitter/X Podcast - @hoopheadspodMike - @hdstarthoopsJason - @jsunkleInstagram@hoopheadspodFacebookhttps://www.facebook.com/hoopheadspod/YouTubehttps://www.youtube.com/channel/UCDoVTtvpgwwOVL4QVswqMLQ

In his weekly clinical update, Daniel Griffin and Vincent Racaniello debate if Senator Mitch McConnell's recent hospitalization is due to post-polio syndrome or just old age, how air quality from Maine to Chicago has been affected by the Ontario wild fires, new screwworm, Legionnaires and cyclosporasis cases, the Ebola outbreak in the Congo and development of a novel vaccine and antiviral, before Dr. Griffin deep dives into the measles outbreak, recent statistics on RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, how to access and pay for Paxlovid, where to go for answers about long COVID-19, long term effects of COVID-19 immune dysfunction including ocular and gut and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Statement From Senator Mitch McConnell (Mitch McConnell US Senator for Kentucky) Polio(NY Department of Health: Polio) Global polio vaccination (CDC) For Some Survivors, Polio Casts a Long Shadow (GAVI) Former Republican Senate Majority Leader Mitch McConnell hospitalized (NPR) Hundreds of thousands of Americans live with the long-term effects of polio (CIDRAP) Child Care, Schools, Camps: Outdoor Air Quality Health Recommendations Based on Air Quality Index (NY City of Health: air quality) Current Air Quality (AirNow) Domestically Acquired Cyclosporiasis Cases in Multiple U.S. States, 2026 (CDC: Health Alert Network) How helpful is not up to date? CDC: cyclosporiasis Top 10 Cyclospora questions (Katelyn Jetelina: your local epidemiologist) Cyclospora, wildfire smoke, and another Legionella outbreak (Marisa Donnelly: your local epidemiologist in New York) Cyclospora keeps climbing, a bad West Nile season, truck spraying, and good news (Katelyn Jetelina and Marisa Donnelly: your local epidemiologists) Infectious Disease Outbreaks (Michigan: Health & Human Services) Cyclospora cases up dramatically in New York (Outbreak News Today) Cyclospora Infection (Cyclosporiasis) (NYC Health) Legionnaires' Disease (NYC Health) New York officials find Legionella in 76 cooling towers as cases hit 63 (CIDRAP) Dashboard SCREWWORM.Gov (USDA: Animal and Plant Health Inspection Service) CDC Activates Emergency Operations Center for New World Screwworm Response (CDC Newroom) Ebola dashboard (ebola.fyi) EBOLA:The Democratic Republic of the Congo, 2026 (WHO) Bundibugyo virus disease outbreak Democratic Republic of the Congo (WHO: Democratic Republic of Congo) Ebola Outbreak: Current Situation (CDC:Ebola) Why the fastest-growing Ebola outbreak in history is becoming more challenging (AP News) Oxford begins first human trial of Bundibugyo Ebola vaccine (Reuters) Gilead launches Ebola antiviral trial in DR Congo as cases near 2,000 (CIDRAP) Information for Travelers Returning from Ebola-Affected Areas (CDC: Ebola) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard (South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) UtahMeasles Dashboard (Utah Department of Health and Human Services) Measles (VDH: Virginia Department of Health) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) FDA vaccine advisers recommend adding subclade K to fall shots (CIDRAP) Weekly surveillance report: cliff notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option(xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Long-term ocular symptoms following COVID-19 linked to immune dysregulation, dysautonomia and peripheral neuropathy (Nature Communications) Vagal cholinergic denervationof the gastric mucosa in Long-COVID-19: in vivo evidence of structural autonomic dysfunction (International Journal of Infectious Diseases) Reaching out to US house representative Letters read on TWiV 1340 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Can you actually grow your brain? Johns Hopkins neurologist Dr. Majid Fotuhi reveals 5 science-backed ways to build brain volume — even in the chaos of parenthood. In this episode of Raising Good Humans Podcast, Dr. Fotuhi breaks down the research on neuroplasticity and brain health, and helps us all understand how measurable brain growth is possible in as little as 12 weeks. What You'll Learn: The 5 pillars of brain health and the minimum effective dose for overwhelmed parents How poor sleep physically shrinks the brain and whether years of damage can be reversed Brain training demystified: why mahjong counts, and a name-memory trick that actually works How to rewrite negative narratives that are quietly working against your brain Your brain isn't declining — it's waiting for the right conditions to grow. The science is more hopeful than you think.

Why Parkinson's disease is now the fastest-growing brain disease in the world. Why environmental toxins may play a much bigger role than genetics than most people realize. How pesticides, air pollution, and contaminated water may contribute to Parkinson's disease. The surprising ways Parkinson's may actually begin in the nose or the gut—years before it reaches the brain. Why losing your sense of smell or acting out your dreams during sleep could be important early warning signs. How scientists are uncovering different pathways that may explain why Parkinson's progresses differently from person to person. Why researchers believe prevention—not just treatment—may be the key to changing the future of this disease. The exciting science behind protecting your brain by reducing everyday environmental exposures and supporting lifelong brain health. Practical takeaways to help you make smarter choices for yourself, your family, and future generations. RAY DORSEY, MD Dr. Ray Dorsey is the director of the Center for the Brain & the Environment at the Atria Health and Research Institute. The center's mission is to identify the root causes of brain diseases from autism to Alzheimer's so that we can prevent them. With his colleagues, he wrote Ending Parkinson's Disease and The Parkinson's Plan, which details a new path to preventing and treating this terrible disease. Ray previously directed the Center for Health + Technology at the University of Rochester, chaired the international Huntington Study Group, led the movement disorders division at Johns Hopkins, and consulted for McKinsey & Company. In 2015, the White House recognized Ray as a "Champion for Change" for Parkinson's disease.     

In this episode of the Award-winning PRS Journal Club Podcast, 2026 Resident Ambassadors to the PRS Editorial Board – Lucas Harrison, Christopher Kalmar, and Priyanka Naidu- and special guest, Seenu Susarla, MD, discuss the following articles from the July 2026 issue: "The APERT Severity Scale: A Quantitative Tool for Risk Stratification in Apert Syndrome" by Hu, Tolley, et al. Read the article for FREE: https://bit.ly/APERTscale Dr. Susarla earned his undergraduate degree from Princeton University, his medical and dental degrees from Harvard, and his MPH from the Harvard School of Public Health. He completed residencies in oral and maxillofacial surgery at Massachusetts General Hospital and plastic surgery at Johns Hopkins, followed by a craniofacial surgery fellowship at Seattle Children's. He has authored more than 250 peer-reviewed publications and numerous textbook chapters, and serves on the editorial boards of several journals, including Plastic and Reconstructive Surgery. READ the articles discussed in this podcast as well as free related content: https://bit.ly/JCJuly26Collection The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.  

Donate (no account necessary) | Subscribe (account required) Join Bryan Dean Wright, former CIA Operations Officer, as he dives into today's top stories shaping America and the world. In this Headline Brief edition of The Wright Report, Bryan reports on the sudden death of GOP Senator Lindsey Graham from a heart attack at age 71, and what his passing means for the Senate math heading into the midterms. Bryan also covers the renewed US Iran conflict flaring over a disputed clause in the peace memo governing the Strait of Hormuz, a surprise Trump Administration decision to extend deportation protections for Haitians and other groups under business pressure, record high asylum rejection rates in Michigan, and Graham Platner's exit from the Maine Senate race as Democrats scout replacement candidates further left. He rounds out domestic coverage with new Pew data on Muslim American attitudes toward Hamas and a big week of inflation and retail sales reports ahead. Plus, a gay cruise ship gets turned away from Turkey and Egypt, new research links daytime sunlight to better sleep, Johns Hopkins warns on marijuana risks for young brains, and a fasting protocol shows promise in easing radiation side effects for cancer patients. "And you shall know the truth, and the truth shall make you free." - John 8:32   Keywords: Lindsey Graham death, South Carolina special election, Scott Bessent, Iran Strait of Hormuz conflict, Trump Iran peace memo, diesel prices global squeeze, Haitian TPS extension, Trump immigration policy, Michigan asylum rejection rates, Graham Platner Maine Senate, Democrat Socialist candidates, Gavin Newsom Democratic Socialism, Pew Research Muslim Americans Hamas, consumer inflation report June, gay cruise ship Turkey Egypt, sunlight sleep research, Johns Hopkins marijuana psychiatric risk, fasting radiation cancer treatment, Wright Report Headline Brief

Why AI Mental Health Chatbots Fail When It Matters Most: The Hidden Vulnerabilities Stress-Testing Reveals - An Interview with Shirali and Arul Nigam of Circuit Breaker Labs Shirali and Arul Nigam of Circuit Breaker Labs on why AI mental health chatbots fail, how stress-testing exposes their hidden vulnerabilities, and what therapists need to know. Curt and Katie talk with Shirali and Arul Nigam, the sibling co-founders of Circuit Breaker Labs, about what therapists tend to get wrong about AI, why the safety infrastructure behind many mental health chatbots is weaker than it looks, and how their team stress-tests these tools to find dangerous failures before real users ever encounter them. Generative AI is probabilistic, so the same prompt can return a safe answer one moment and a harmful one the next. Shirali and Arul explain how guardrails get bypassed by a misspelled word, a teenager's slang, or the hundredth message in a long conversation, why mental health chatbots tend to fail in the moments that matter most, and what stress-testing hundreds of thousands of simulated conversations actually reveals about model safety. The conversation closes on what clinicians can do now, why clinical insight is the missing ingredient in AI safety, and why third-party validation is becoming the standard regulators and developers expect. Used well, AI can be a supplement to care or a gateway to a human therapist, but it is not a replacement, and getting there safely starts with building clinical insight in from the foundation. In this episode, we discuss: - Why people usually turn to AI in place of no care, not in place of a therapist - Why generative AI's unpredictability, not a single bad answer, is the real safety problem - How a misspelling, slang, or a long conversation can slip past chatbot guardrails - Why AI mental health chatbots tend to fail in the highest-risk moments - What stress-testing hundreds of thousands of conversations reveals about model safety - Why clinical insight is the missing ingredient, and what clinicians can do now Timestamps: 0:00 - Introduction 1:38 - Meet Shirali and Arul Nigam and Circuit Breaker Labs 3:37 - What therapists get wrong about AI 5:28 - Deterministic versus generative AI, and why the risk scales 8:26 - The safety problem in AI mental health: trust, training data, and agreeableness 11:29 - Guardrails, lifeguard models, and the 988 problem 17:30 - Deploying clinical insight at scale and building safety in from the start 21:09 - How stress-testing works: context pollution and adversarial simulation 27:11 - What the stress tests reveal: variance, typos, and bypassed guardrails 30:59 - Regulation, credential hallucination, and third-party validation 36:58 - What clinicians can do, and the missing clinical insight 40:20 - Where to find Circuit Breaker Labs Guest Bios: Shirali and Arul Nigam are siblings and the co-founders of Circuit Breaker Labs, which autonomously pressure-tests the AI systems that interact with people to find hidden mental health vulnerabilities before they reach real users. Shirali brings expertise in neuroscience, translational research, and clinical work, with experience at the Howard Hughes Medical Institute's Janelia Research Campus, NIH NINDS, Harvard's Wyss Institute, Johns Hopkins, and Children's National. She holds a BS in Biomedical Engineering from The George Washington University and an MBA from The Wharton School, University of Pennsylvania. Arul has conducted technical and policy research on ethical AI, with a focus on bias and fairness, at Georgetown University and Thomas Jefferson High School for Science and Technology, and holds a BSBA in Operations and Analytics from Georgetown University. Learn more at circuitbreakerlabs.ai. Full show notes and transcript: mtsgpodcast.com Join the Modern Therapist Community Patreon: https://www.patreon.com/c/mtsgpodcast Facebook Group: https://www.facebook.com/groups/therapyreimagined Modern Therapist's Survival Guide Creative Credits Voice Over by DW McCann: https://www.facebook.com/McCannDW/ Music by Crystal Grooms Mangano: https://groomsymusic.com/

In his weekly clinical update, Daniel Griffin and Vincent Racaniello are dismayed over the military deaths due to the voluntary influenza vaccination policy, FDA's first vaccine recommendations since 2023, the efficacy of influenza vaccines, new screwworm, Legionnaires and cyclosporiasis cases, the Ebola outbreak in the DRC and Uganda and before Dr. Griffin deep dives into the measles outbreak, recent statistics on RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, how to access and pay for Paxlovid, publication of the blocked COVID-19 vaccine findings, where to go for answers about long COVID-19, use of antivirals in children with COVID-19, severe West Nile disease and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode A1C Keon Talik McDaniel (Bexar Memorial) Hegseth: Flu Vaccine Optional (US Department of War) Air Force trainee in San Antonio, Texas, died from flu(CIDRAP) Key FDA committee unanimously recommends its first vaccine since 2023(NPR) Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults (NEJM) Influenza Vaccine Effectiveness Against Pediatric Death in the United States: 2016–2025 (Pediatrics) Dashboard SCREWWORM.Gov (USDA: Animal and Plant Health Inspection Service) CDC Activates Emergency Operations Center for New World Screwworm Response (CDC Newroom) Upper East Side Legionnaires' Outbreak Source Remains Unknown (Bloomberg) Outbreak of diarrhea-causing parasite grows to more than 1,000 cases (AP) Cyclosporiasis outbreak in Michigan exceeds 1,000 cases (WOODTV+) Ebola deaths top 500 as DR Congo health workers threaten to strike (CIDRAP) Ebola deaths in Congo top 500 as health workers threaten to strike (AP) Ebola dashboard (ebola.fyi)  EBOLA:The Democratic Republic of the Congo, 2026 (WHO) Bundibugyo virus disease outbreak Democratic Republic of the Congo (WHO: Democratic Republic of Congo) Ebola Outbreak: Current Situation (CDC:Ebola) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard (South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) Utah Measles Dashboard (Utah Department of Health and Human Services) Measles (VDH: Virginia Department of Health) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) FDA vaccine advisers recommend adding subclade K to fall shots(CIDRAP) Weekly surveillance report: cliff notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Nirmatrelvir/Ritonavir for the Treatment of COVID-19 in Children Aged 6 Years and Older (Pediatrics) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Efficacy and safety of rivaroxaban, colchicine, and famotidine–loratadine with specialist supportive clinical care for fatigue in patients with post-COVID-19 condition in the UK: a multisite, open-label, randomised controlled trial (LANCET: Infectious Diseases) Long-term Sequelae Associated With Severe West Nile Virus Disease in Maricopa County, Arizona, 2021 (OFID) Reaching out to US house representative Letters read on TWiV 1338 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

El 27 de abril de 1966, un bebé de ocho meses entró a quirófano para una circuncisión de rutina. El procedimiento usaba corriente eléctrica. Algo salió mal. Sus padres encontraron un nombre: John Money, de Johns Hopkins. Money tenía una teoría y un grupo de control perfecto: el hermano gemelo idéntico. Les propuso criar al bebé como una niña, cambiarle el nombre y no contarle jamás la verdad.  Durante años, los informes científicos celebraron el éxito. Pero la persona que vivía dentro del experimento nunca se sintió como describían esos informes. A los catorce años le contaron la verdad. Eligió llamarse David. Construyó una vida.  El 4 de mayo de 2004, se quitó la vida. Tenía treinta y ocho años. El experimento más citado del siglo XX había sido, desde el principio, una mentira.

Fifty years ago the U.S. government classified it alongside heroin: no accepted medical use, high potential for abuse, illegal in most of the world. The peer-reviewed data now coming out of Johns Hopkins, Imperial College, and Nature tells a different story, one that has some of the most credentialled neuroscientists alive rethinking how the brain heals. In this episode, Louisa breaks down exactly what psilocybin does to your neurons, why it works where antidepressants stall for decades, and where the research is heading right now. She walks through the default mode network, the self-referential system that turns rigid and hyperactive in depression, and the 2024 Nature study that described psilocybin's effect on it as "massive" disruption. You'll hear how a single dose drove a measurable jump in dendritic spine density within 24 hours, why psilocin binds the TRKB receptor 300 times more strongly than any conventional antidepressant, and how Robin Carhart-Harris's head-to-head trial against escitalopram produced more than double the remission rate. Then she turns to addiction, where psilocybin-assisted therapy reached an 80% smoking abstinence rate at six months in the Johns Hopkins pilot, more than double the best medication available today. She covers the risks the drug-war narrative leaves out, the hard contraindications around psychosis and cardiac history, the April 2026 executive order that accelerated federal review, and why the quality of the subjective experience, measured on the Mystical Experience Questionnaire, may matter to the outcome as much as the molecule itself. You'll also hear about the desynchronization event and what fills the space when the network goes offline, BDNF and how it stacks up against high-intensity exercise, the alcohol and opioid data, HPPD, Australia's 2023 reclassification, Oregon and Colorado's state access frameworks, and why set and setting may be active ingredients in how the treatment works. Fifty years ago the U.S. government classified it alongside heroin: no accepted medical use, high potential for abuse, illegal in most of the world. The peer-reviewed data now coming out of Johns Hopkins, Imperial College, and Nature tells a different story, one that has some of the most credentialled neuroscientists alive rethinking how the brain heals. In this episode, Louisa breaks down exactly what psilocybin does to your neurons, why it works where antidepressants stall for decades, and where the research is heading right now. She walks through the default mode network, the self-referential system that turns rigid and hyperactive in depression, and the 2024 Nature study that described psilocybin's effect on it as "massive" disruption. You'll hear how a single dose drove a measurable jump in dendritic spine density within 24 hours, why psilocin binds the TRKB receptor 300 times more strongly than any conventional antidepressant, and how Robin Carhart-Harris's head-to-head trial against escitalopram produced more than double the remission rate. Then she turns to addiction, where psilocybin-assisted therapy reached an 80% smoking abstinence rate at six months in the Johns Hopkins pilot, more than double the best medication available today. She covers the risks the drug-war narrative leaves out, the hard contraindications around psychosis and cardiac history, the April 2026 executive order that accelerated federal review, and why the quality of the subjective experience, measured on the Mystical Experience Questionnaire, may matter to the outcome as much as the molecule itself. You'll also hear about the desynchronization event and what fills the space when the network goes offline, BDNF and how it stacks up against high-intensity exercise, the alcohol and opioid data, HPPD, Australia's 2023 reclassification, Oregon and Colorado's state access frameworks, and why set and setting may be active ingredients in how the treatment works. *Reduce your risk of Alzheimer's with my science-backed protocol for women 30+: * https://go.neuroathletics.com.au/youtube-sales-page Subscribe to The Neuro Experience for evidence-based conversations at the intersection of brain science, longevity, and performance. _____ *TOPICS DISCUSSED* 00:00 Intro: A Schedule I Drug That's Making Neuroscientists Rethink the Brain 00:39 The Default Mode Network and Your Sense of Self 02:49 How Depression Locks the Brain Into a Rigid Loop 03:23 Where SSRIs Stop Short of the Problem 04:44 The Brain Imaging Data: "Massive" DMN Disruption and Reorganization 06:58 Confirming It in Drug-Naive Brains 08:04 The Rewiring: How Psilocybin Changes Neural Architecture 08:35 Dendritic Spines and Synaptic Density 09:39 How Chronic Stress Shrinks Your Neural Connections 10:16 One Dose, More Connections in 24 Hours (Neuron 2021) 11:02 BDNF, TRKB, and a Signal 300x Stronger Than Antidepressants 13:21 Psilocybin vs the Gold-Standard SSRI 14:37 Double the Remission Rate: The Numbers That Matter 15:53 Side Effects, Durability, and Treatment-Resistant Depression 16:39 The Addiction Breaker: 80% Smoking Abstinence at Six Months 17:36 Alcohol, Opioids, and the Shared Architecture of Addiction 19:10 The Dark Side: Real Risks and Hard Contraindications 22:35 The Policy Earthquake: Executive Orders and FDA Breakthrough Status 24:37 Why It Actually Works: Set, Setting, and the Mystical Experience 26:57 Bringing It All Together _______ *Thank you to our sponsors* Function Health: https://functionhealth.com/LouisaNicola Use code NEURO25 for a $25 credit BASED Bodyworks: https://basedbodyworks.com/ Use code NEURO for 20% off (plus a free toiletry bag with any set) BioOptimizers: https://www.bioptimizers.com/neuro Use code NEURO for 15% off IQBAR: Text NEURO to 64000 for 20% off all IQBAR products plus FREE shipping (Message and data rates may apply) Learn more about your ad choices. Visit megaphone.fm/adchoices